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Abstract 
 
Many cellular processes require specific RNAs to be transported to distinct compartments 
where they may be translated or stored until activation. These RNAs are packaged into RNPs 
(ribonucleoproteins), which then travel into dendrites near synapses. Defects in this process 
have been associated with severe neurological disorders including X-linked mental 
retardation. One well-known example of a localized RNA in neurons is the β-actin transcript, 
which localizes to the leading edge of growth cones and neurites resulting in morphological 
rearrangements of the cytoskeleton, which occur during neuronal development and 
synaptic plasticity. Two trans-acting factors have been implicated in this process: (i) ZBP1 
(zipcode-binding protein 1) that binds to a 54-nt localization element in the β-actin 3´-UTR 
(the so-called “zipcode”) and that represses its translation during transport; and (ii) the 
double-stranded RNA-binding protein Staufen2 (Stau2), which was suggested to be 
necessary for the localization of β-actin to dendrites and for the formation of dendritic 
spines in mature neurons. In contrast to ZBP1, however, a defined molecular action of Stau2 
on its target has yet to be described.   
The aim of my thesis was to characterize the role of Stau2 in the regulation of β-actin 
in developing neurons. To achieve this, β-actin levels were quantified after Stau2 
knockdown in developing primary hippocampal neurons. Whilst mRNA levels were slightly 
reduced, β-actin protein levels were unchanged. To examine more directly whether Stau2 
controls β-actin translation, as described for ZBP1, luciferase assays were performed. 
Knockdown of Stau2 had no effect in this assay, whereas overexpression of either Stau2 or 
ZBP1 increased the activity of luciferase when fused to the β-actin zipcode and part of the 
coding region. As this assay does not discriminate between enhanced translation and 
stability, RNA decay assays were carried out. The amounts of residual β-actin mRNA at 
different time points after inhibition of RNA synthesis were quantified using quantitative 
real-time PCR. The decay of β-actin mRNA was accelerated in neurons upon Stau2 
knockdown. In contrast, overexpression of Stau2 only had a minor stabilizing effect.  
Taken together, my findings indicate that the RNA-binding protein Stau2 increases 
the stability of β-actin transcripts in developing neurons without affecting its translation. As 
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overall levels of β-actin were not changed, it is conceivable that Stau2 transiently promotes 
stabilization during transport, in a similar manner as ZBP1 acts on β-actin during localization 
of the transcript to inhibit premature translation. Whether β-actin mRNA binds Stau2 
directly, possibly dependent on a sequence within the coding region, and whether it 
interacts with ZBP1 in the same RNPs could be an interesting topic for future investigations. 
To fully understand the functions of Stau2-RNPs, it will be necessary to clarify the identity of 
RNA targets and protein interactions of Stau2 and to describe the actions of Stau2 during 
transport or at the synapse and growth cone in detail. 
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I  Introduction 
1.1 Different mechanisms of regulation of localized mRNAs  
 
With every new experience and thought, connections are formed between the nerve cells 
that are the substance of our mind. An estimated 1014 to 1015 synapses are believed to exist 
in the human brain, a number which is difficult to visualize, even exceeding the entirety of 
stars in our galaxy (Kandel, 2000). The plasticity of these connections is the foundation of all 
higher brain functions, such as learning and memory. It is widely accepted that synaptic 
remodeling is dependent on protein synthesis, which has shown to be vital for long-term 
memory formation (Barzilai et al. 1989, Kelleher et al. 2004; Brightwell et al., 2007; Klann 
and Sweatt, 2008) Before polyribsosomes were discovered at the base of spines in the early 
80´s, proteins were thought to be produced uniquely in the cell body compartment and 
then had to be transported to distant sites in the neuron (Martin and Zukin, 2006). Since 
then, studies have investigated the role of local protein synthesis “on site” in morphological 
rearrangements, a model which has several advantages. First, the localization of transcripts 
provides a way to spatially restrict gene expression within the cytoplasm, so that changes in 
protein synthesis could occur independently at individual activated synapses of a neuron. 
Secondly, if local stimuli can regulate translation directly, higher temporal resolution can be 
obtained. This “short-cut” circumvents the lengthy process of delivering the signal to the 
nucleus to initiate transcription, export of mRNA and cytoplasmic translation followed by 
targeting of the protein to the site of stimulation. On top of that localized transcripts can be 
translated multiple times, which is much more economic than the transport of many copies 
of a protein, especially as the processes of a neuron can extend very far from their cell 
bodies (Martin and Ephrussi, 2009). These also include axons, as local synthesis does not 
only occur in dendritic regions. During neuronal development, the axonal growth cone has 
to react to attractive and aversive cues to find their distant target regions. β-actin mRNA in 
Xenopus growth cones was shown to rapidly localize in response to an attractive stimulus 
gradient (Leung et al., 2006). 
Classes of mRNAs localized in neurons include for example cytoskeletal proteins (e.g. MAP2, 
Arc), kinases (CaMKIIα, PKCζ), and Calcium-binding proteins (dendrin) or neurotransmitter 
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receptors. A variety of post-transcriptional mechanisms can regulate these mRNAs either 
during transport or local protein synthesis, which range from stabilizing or destabilizing 
factors altering the half-lives of the transcripts to mechanisms for repression or activation of 
translation. A few of these regulatory mechanisms which have been described in neurons 
shall be presented here. 
 
1.1.1   Trans-acting factors influencing RNA stability in mammalian neurons 
Posttranscriptional mechanisms act on message RNAs at various stages, including splicing, 
mRNA editing, transport, stability and translation. The stability of an mRNA determines the 
time it will be available for translation before it gets degraded by ribonucleases. While 
mRNAs for house-keeping genes usually have long half-lives, some mRNAs decay quickly to 
ensure low steady-state levels and concise temporal expression. Modest increases in the 
half-lives of transcripts can result in considerable augmentation of expression levels. Such 
changes of stability can be conferred by trans-acting factors, i.e. RNA-binding proteins 
(RBPs), which bind to recognition motifs of the mRNA sequence. These motifs, or cis-acting 
elements, are often situated in the 3’-UTR of transcripts. A well-studied example of such a 
3’-UTR sequence is the ARE (adenylate-uridylate rich element), which is found in multiple 
gene families, such as immediate early genes, oncogenes and cytokines (Chen and Shyu, 
1995). AREs are able to stabilize transcripts by binding of Hu proteins (homologue of 
Drosophila ELAV; Keene, 1999), while binding of other factors triggers their degradation. 
Binding of either AUF1 or KSRP (K homology splicing regulatory protein), which is expressed 
in neurons, induces the exosome mediated degradation pathway by recruiting the exosome 
to targeted transcripts (Chen et al., 2001). Another decay pathway involves exonucleases in 
cytoplasmic processing bodies (P-bodies), foci of local degradation which are also present in 
neurons and dendrites. P-bodies are dynamic multiprotein complexes including RBPs, 
decapping enzymes and the 5’-3’ exonuclease Xrn1p, but no ribosomes (Anderson and 
Kedersha, 2006). Degradation in P-bodies can also be mediated by microRNAs (Eulalio et al., 
2007). 
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Fig 1.1. Simplified model of mRNA stabilization and decay. After being exported into the cytoplasm, 
mRNAs can be either stabilized and translated on polyribosomes or destabilized and degraded, 
depending on the trans-acting factors they bind. mRNA decay is initiated by deadenylation and 
decapping, followed by 3’- 5’ degradation of the exosome or 5’- 3’ decay of exonucleases in P-bodies 
(taken from Bolognani and Ferrone-Bizzozero, 2008). 
Regulation via mRNA stability is important for several classes of neuronally expressed genes 
including neurotransmitter receptors, signaling molecules and proteins implicated in 
neuronal development, such as GAP-43. The stability of GAP-43 mRNA is controlled by HuD 
protein which binds the ARE in its 3’-UTR. Altering HuD levels in neurons was shown to 
cause both changed GAP-43 mRNA levels as well as significant changes in neurite outgrowth 
(Anderson et al., 2000). The relevance of mRNA-stabilizing and -destabilizing proteins in 
neurons was demonstrated in different studies, showing for example that Hu protein levels 
are increased after learning and memory tasks (Quattrone et al., 2001), or that trans-acting 
factors like AUF1 are themselves regulated by neuronal activity, simulated by addition of 
NMDA to granule cell cultures (Jurado et al., 2006). 
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1.1.1.1   The EJC factor eIF4AIII and translation-dependant decay 
eIF4AIII is a DEAD-box protein and a core component of the exon junction complex (EJC). It 
is loaded onto mRNAs by pre-mRNA splicing and is associated with dendritic mRNAs and 
neuronal RNA granules. The EJC- eIFAIII, Y14, MAGOH, and Barentsz being its core 
constituents- is deposited upstream of exon-exon junctions in the nucleus and serves as a 
binding platform for other factors. The loaded mRNAs travel to the cytoplasm, where EJCs in 
ORFs can positively influence ribosome recruitment, while those downstream of an ORF can 
trigger nonsense-mediated decay (NMD) (Giorgi et al., 2007). This evolutionarily conserved 
mRNA surveillance mechanism targets mRNAs harboring premature termination codons 
(PTCs) for degradation to prevent accumulation of truncated proteins with potentially 
harmful gain-of-function or loss-of-function. But NMD does not only downregulate aberrant 
RNAs, it also modulates expression of natural NMD targets (e.g. mRNAs with introns in the 
3’-UTR), initiated by interaction of the NMD factor Upf1 and ribosomes stalled at the 
termination codon after the pioneer round of translation (Chang et al., 2007). One of the 
targets of eIF4AIII is Arc mRNA, which is produced after synaptic activation and delivered to 
dendrites and possesses 2 introns in its 3’-UTR. Arc mRNA and protein levels increase after 
BDNF stimulation or eIF4AIII knockdown in neurons, which also leads to an increase of 
synaptic strength (Giorgi et al., 2007).  
Substrates of this translation-dependant decay remain stable as long as they are 
translationally silent and can thus accumulate at distal dendritic sites, until an external 
signal relieves this repression. After the first round of translation, NMD quickly stops protein 
synthesis which guarantees a highly timed response, making this mechanism key regulator 
for a precise control of protein expression in neurons. The Upf (up-frameshift) proteins are 
trans-acting factors at the core of the NMD machinery and are recruited to mRNAs by the 
EJC. Eukaryotic suppressors with morphogenetic defects in genitalia (SMG) proteins mediate 
the phosphorylation status of Upf1, an RNA helicase, and recruit it to P-bodies, where 
degradation occurs. 
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1.1.1.2    Staufen1 
Other factors can also elicit translation-dependent decay through Upf1 interaction, for 
example Stau1 (Staufen1). Stau1 can initiate degradation of targets after binding to sites 
more than 25 nucleotides downstream of a termination codon and recruitment of Upf1. A 
well-known target of Staufen-mediated decay is Arf1 mRNA (ADP ribosylation factor 1), 
which binds Stau1 with a 19bp stem-loop in its 3’UTR (Kim et al., 2007). SMD-targets which 
contain Alu elements in their 3´UTR were suggested to form double-stranded binding sites 
for Stau1 by base-pairing with cytoplasmic, long non-coding RNA (lncRNA), also carrying an 
Alu element (Gong and Maquat, 2011). In contrast to NMD, SMD does not require targets to 
have undergone splicing, and while NMD also has a broader function in the general quality 
control of transcripts, Staufen-mediated decay is thought to conditionally regulate the 
expression of specific genes.  
1.1.1.3    FMRP 
Many RBPs that control stability also play a role in the regulation of translation, possibly to 
couple these two processes. One of them is the Fragile X mental retardation protein (FMRP), 
a protein which is transported into dendrites and found in association with polyribosomes.  
The name-giving disease, the fragile X syndrome, is caused by aberrant expansion of the 
CGG-triplet in the 5’-UTR of the FMR1 gene, which leads to a loss of FMRP expression. In the 
absence of FMRP, dysregulated local protein synthesis leads to a disturbance of synaptic 
plasticity. FMRP regulates local translation of specific mRNAs at the synapse in response to 
activation of metabotropic glutamate receptors (Bassell and Warren, 2008). Its targets 
include CaMKIIα, MAP1b, Arc and Rac1 mRNA.  
When FMRP interacts with the cytoplasmic FMRP interacting protein 1 (CYFIP1), which in 
turn binds the cap-binding factor eIF4E, translational activity is repressed. Upon synaptic 
stimulation, this complex dissociates and protein synthesis can be initiated (Napoli et al., 
2008). Yet neuronal activity is also able to entail stabilizing effects of FMRP.  FMRP was 
shown to protect PSD-95 mRNA, a scaffolding protein of the postsynaptic density, from 
degradation in the hippocampus (De Rubeis and Bagni, 2009). Its stabilizing activity could be 
regulated by various aspects, such as subcellular context or interacting proteins. 
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1.1.2 Translation control in neurons 
Synaptic activity stimulates the transport of mRNAs into dendrites and local mRNA 
translation. If mRNAs were simultaneously translated during transport, newly made proteins 
would not specifically tag activated synapses, but would be distributed all over the dendrite. 
Thus the synthesis of the encoded protein must be repressed until the mRNA arrives at its 
site of action. The major target of translation control is the initiation step, which is the rate-
limiting step in the process. 
The translation of specific mRNAs is regulated by trans-acting factors binding their 5’- or 3’-
UTR. Translational regulators can be controlled by kinases or phosphatases, which are 
activated by Ca2+ influx. The PI3K/Akt/mTOR and the MAPK/Erk signaling pathways were 
shown to be involved in stimulating local translation at the synapse, thereby regulating 
synthesis-dependant LTP (Panja et al., 2009). Especially developing synapses lacking scaffold 
proteins, such as PSDs that trap and anchor other proteins, need local synthesis to rapidly 
control the concentration of specific proteins (Zha et al., 2009). 
The translational regulation of localized mRNA does, however, not only play a role in 
dendrites and synapse function. The extreme distances between soma and axonal growth 
cones combined with the relatively slow rate of protein transport make local protein 
synthesis indispensable for axon outgrowth and development. Yet mature axons seem to be 
devoid of the translational machinery. In developing axons several mRNAs were found, for 
example β-actin, β-tubulin, cofilin, ADF, amongst others. While it is not yet clear that 
translational inhibition would inhibit axon elongation, a rapid growth cone response to 
external cues in the environment seems to depend on fast local translation, for example the 
rapid synthesis of RhoA. This is a critical upstream regulator of the cytoskeleton, which is 
necessary for the collapsing effect in response to the guidance cue Sema3A. Local 
translation could also amplify signal transduction pathways by strongly increasing rate-
limiting proteins. Asymmetric β-actin translation at precise sites within growth cones 
appears to define the directionality of netrin1-induced, Ca2+-dependant growth cone 
turning. Microtubule-dependant transport of β-actin may be insufficient in this case, as the 
edges of growth cones are actin-rich but hardly contain microtubules. Studies of fibroblast 
migration suggested a similar mechanism (Hengst and Jaffrey, 2007). 
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1.1.2.1   ZBP1 
 
A well studied example of a regulator of local translation in neurons is ZBP1 (zipcode-
binding protein 1), sometimes also termed IMP1 or IGFIIBP1 (IGF-II mRNA binding protein 
1). ZBP1 belongs to the highly conserved VICKZ family of RNA-binding proteins that 
recognize cis-acting elements in various RNAs (Yisraeli, 2005). It was discovered by affinity 
purification with the “zipcode” sequence of β-actin mRNA and subsequently cloned (Ross et 
al., 1997). This so-called zipcode is a 54-nt element in the 3’-UTR of the β-actin mRNA that is 
sufficient for correct localization of the transcript.  
ZBP1 is an mRNA-binding protein containing 4 KH- and 1 RRM-RNA binding domains, as well 
as a nuclear export and import sequence (Oleynikov and Singer, 2003). During nuclear 
priming, the protein associates with its target RNA cotranscriptionally. Initially the nascent 
transcripts in the nucleus are bound by ZBP2, which facilitates the subsequent binding of 
the shuttling ZBP1 (Pan et al., 2007). ZBP1-granules show rapid anterograde and retrograde 
dendritic transport along microtubules and dynamic movements into dendritic spines. By 
binding cis-acting sequences, ZBP1 may act as an adapter between mRNAs and the 
transport machinery. In the case of β-actin mRNA, transcripts can be exported into the 
cytoplasm independently of ZBP1, which is, however, crucial for their localization to 
dendrites. This trafficking is activity-dependent and can be stimulated by KCl depolarization 
(Tiruchinapalli et al., 2003).  
Throughout the transport, ZBP1 prevents translation initiation in the cytoplasm, possibly by 
inhibiting the formation of the 80S ribosomal complex on its target mRNA. When the 
transcript has reached its destination, translation repression is relieved by the non-receptor 
tyrosine kinase Src, the activity of which is restricted to the cell periphery. ZBP1 contains an 
SH3-binding motif, which is a docking site for this enzyme. Src phosphorylates ZBP1 at 
Tyrosine 369, required for RNA binding, thereby releasing the trans-acting factor from the 
complex (Fig. 1.2; Hüttelmaier et al., 2005). Reduced dendritic levels of ZBP1 impair neurite 
outgrowth and result in a failed response to BDNF treatment, which otherwise increases the 
density of dendritic filopodia and synapses (Eom et al., 2003).            
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Fig 1.2  Localization and silencing of β-actin mRNA in neurons. Hüttelmaier et al. suggest that ZBP1 
protein binds β-actin mRNA in the nucleus and is exported into the cytoplasm, where it is delivered 
into neurites in a complex associated with ribosomal subunits and motor proteins. The latter 
transport the ZBP1 granules along microtubules to their destination in the periphery, where the 
ZBP1-mediated repression of its target is relieved. Src kinase phosphorylates ZBP1, which gets 
released from β-actin mRNA and allows ribosomal subunits to assemble and initiate local protein 
synthesis (taken from Dahm and Kiebler, 2005). 
 
Yet suppressing translation of target mRNAs is not the only known regulatory function of 
ZBP1, it also plays a role in mRNA stabilization in some cases. Under stress conditions, 
mRNAs are retained in stress granules to prevent premature decay in P-bodies. While 
targeting of mRNAs to stress granules happens in a nonspecific manner, specific protein–
mRNA interactions are involved in stabilizing mRNAs. During the ISR (integrated stress 
response), ZBP1-knockdown leads to a selective destabilization of target transcripts, and 
ZBP-1 overexpression increases mRNA stability (Stöhr et al., 2006). RNA-binding proteins like 
ZBP1 are essential for translational adaptation during cellular stress by modulating mRNA 
turnover.  
A different type of mRNA stabilization mediated by ZBP1 requires interaction with a CRD 
(coding region determinant), a sequence in the open reading frame of specific mRNAs, such 
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as c-myc. ZBP1 promotes CRD-mediated stabilization of c-myc mRNA, associated with 
several other proteins in an RNA–dependent fashion. This complex formation at the CRD 
seemingly suppresses the transfer of the mRNA to the polysomal fraction, thereby 
preventing translation-coupled decay (Weidensdorfer et al., 2009). 
 
1.1.2.2   CPEB and Staufen1 
Another protein that facilitates translationally silenced mRNA transport to dendrites is 
cytoplasmic polyA binding protein (CPEB) (Richter, 2007; Bestman and Cline, 2008). 
Polyadenylation is controlled by binding of CPEB to a cytoplasmic polyadenylation element 
(CPE), a cis element in the 3’-UTRs of specific mRNAs. CPE has been shown to be sufficient 
to direct a reporter RNA into dendrites of hippocampal rat neurons in a microtubule-
dependent fashion. In neurons derived from CPEB knockout mice, the dendritic transport of 
a CPE-containing reporter RNA is reduced (Huang et al., 2003). A well-studied example is the 
CPE-containing CaMKIIα mRNA, which is polyadenylated and translated upon synaptic 
stimulation. 
CPEB-containing particles also contain the molecular motors dynein and kinesin as well as 
Maskin, a CPEB-associated factor that mediates cap-dependent translational repression of 
CPE-containing mRNA. Maskin interacts with both CPEB and the cap-binding factor eIF4E, 
and thus suppresses eIF4E–eIF4G interaction, which is necessary to position the 40s 
ribosomal subunit on the mRNA to initiate translation. It dissociates upon polyadenylation, 
thereby stimulating translation (Cao and Richter, 2002). Polyadenylation is initiated when 
Aurora phosphorylates CPEB. Phosphorylation induces CPEB to interact and possibly 
stabilize CPSF (cleavage and polyadenylation specificity factor), which is believed to be 
necessary for the recruitment of poly(A) polymerase (Mendez et al., 2000). 
 The RBP Stau1 has been mentioned above as factor that elicits degradation when bound 
downstream of a natural termination codon by recruiting Upf1 to specific 3’-UTRs. 
Additionally, Stau1 is able to enhance translation of a subpopulation of transcripts 
containing structured 5’-UTRs. Fusing a structured HIV1-TAR element to the 5’-end of a 
luciferase reporter mRNA resulted in upregulation of reporter activity in mammalian cells 
that were co-transfected with Stau1, while unstructured 5’-ends did not have this effect. 
The interaction between transcripts and ribosomes mediated by Stau1 is thought to 
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facilitate translation intiation (Dugré-Brisson, 2005). Downregulation of Stau1 by siRNA led 
to a decrease of dendritic mRNAs. Mutant mice expressing a truncated Stau1 protein lacking 
a crucial RNA-binding domain displayed deficits in the dendritic transport of Stau1-
containing RNPs. While behavioural deficits in these mice were limited to locomotor activity, 
the development of synapses was notably impaired (Vessey et al., 2008). 
 
1.1.2.3 Other mechanisms for translational silencing 
 
Another possibility of post-transcriptional regulation of gene expression is the regulation by 
small non-coding RNAs, which can act either by cleavage of target transcripts or by reducing 
translational efficiency, depending on the degree of sequence complementarity. Silencing of 
translation by microRNAs usually has a rather moderate effect on expression levels and 
functions via competition for binding of the cap structure. Fine-tuning of expression by 
miRNAs often relies on combinatorial actions: one miRNA can inhibit up to 10 different 
mRNAs, and one mRNA can be targeted by different miRNAs.  
An example of a brain-specific miRNA is miR-134 which is found in synaptic compartments 
(Schratt et al., 2009). The level of miR-134 in neurons peaks at postnatal day 13, at a time 
when synaptic maturation occurs. It has a partially complementary conserved target 
sequence in the 3’-UTR of LimK1 (Lim domain-containing protein kinase 1) mRNA. LimK1 
regulates actin filament dynamics through inhibition of ADF (actin binding/depolymerizing 
factor) and cofilin, thus stabilizing the actin cytoskeleton and controlling dendritic spine size. 
Dendritic spines of LimK1 KO mice have an abnormal structure, a phenotype also seen upon 
miR-134 overexpression. miR-134 decreased the activity of a luciferase reporter containing 
the LimK1 3’-UTR, reducing the translation of this reporter fused to myr-GFP locally in 
dendrites (Schratt et al., 2006). The repression of LimK1 translation can be relieved by 
treatment with BDNF, which is known to promote dendritic spine growth. 
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1.2 RNA transport and localization  
RNA localization is an evolutionary old mechanism employed by different organisms, for 
example budding yeast, where ASH1 mRNA localizes to the daughter cells and thereby 
specifies different mating types between mother and daughter cell (Paquin and Chartrand, 
2008). RNA localization is also important for the establishment of the body axes and 
patterning in Drosophila and Xenopus oocytes as well as for cell fate determination in the 
asymmetric division of neuroblasts in the Drosophila embryo. Moreover, the localization of 
mRNAs is involved in various processes in mammals, for instance the regulation of the actin 
cytoskeleton in migrating fibroblasts (Condeelis and Singer, 2005), the formation of myelin 
sheaths by oligodendrocytes or the development of neurons (Dahm et al., 2007). Several 
neurological diseases are associated with defective subcellular RNA localization, such as X-
linked mental retardation, spinocerebellar ataxia and spinal muscular atrophy. In many 
cases, abnormal neuronal development is caused by mutations affecting the RNA transport 
machinery, such as the triplet repeat expansions in the FMR1 (fragile X mental retardation 
1) gene, which cause loss of function of the RBP FMRP. Some of its target mRNAs encode 
proteins that are essential for dendritic spine formation (Dahm and Macchi, 2007).  
There are essentially three main mechanisms by which RNA localization can be achieved: 
locally trapping mRNAs that are diffusing through the cytoplasm, selective stabilization of  
transcripts at certain cellular compartments, while they are degraded everywhere else, and 
active and directed transport of mRNAs (Martin and Ephrussi, 2009). The latter seems to be 
the predominant mechanism of localization, as it presents a method of rapid translocation 
of large particles over long distances. RNA transport follows a multistep pathway (Fig. 1.3) 
that starts in the nucleus. Nuclear events, such as alternative splicing or polyadenylation, 
can generate isoforms with different targeting specificities. The “cellular address” of an 
mRNA is usually defined by cis-acting elements (also called localization elements), consisting 
of nucleotides sequences or secondary structures, which are often found in the 3’-UTR and 
bind to specific trans-acting proteins. After being exported to the cytoplasm, additional 
proteins may assemble on the mRNA. Studies suggest that there are multiple species of RNA 
granules containing distinct populations of RNA and proteins. The newly formed 
ribonucleoprotein particles (RBPs) are then transported along microtubules with the aid of 
kinesin motors. Trafficking of RNA granules in dendrites is dependent on the anterograde 
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motor protein Kinesin heavy chain or KIF5 (Kanai, 2004). Translation of the transcripts needs 
to be repressed during this process. In the case of dendrites, RNPs are thought to be 
anchored at the base of spines, until synaptic activation induces their localization into the 
synaptic compartment by actin-based myosin motor proteins. Repression is subsequently 
relieved and ribosomes can initiate protein synthesis. 
 
 
Figure 1.3 – The multistep pathway of RNA localization in neurons. RBPs associate with specific 
RNAs in the nucleus and are exported to the cytoplasm, where additional proteins can bind to the 
mRNA. RNA and trans-acting factors are packaged into RBPs, kinesin and dynein motor proteins then 
move them along microtubules. Translation of the localized transcripts remains silenced during 
transport. When the RNPs have reached their destination in the dendrite (1), they are thought to be 
anchored at specific sites, such as the base of dendritic spines. Upon synaptic activation (2), 
translational repression is relieved which allows the ribosome to assemble and initiate local protein 
synthesis (from Dahm et al. 2007).  
 
The regulation of local protein synthesis is also thought to be dependent on actin dynamics, 
due to the fact that ribosomes are often found in association with F-actin (filamentous actin) 
in neurons and that many initiation and elongation factors are actin-binding proteins. The 
actin cytoskeleton on the other hand is modulated itself by local translation of various RNAs, 
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such Arc, RhoA, LimK1 or β-actin mRNA. Thus in a model of reciprocal interaction, dendritic 
mRNA translation leads to actin polymerization, which enhances local protein synthesis 
through the activation of the translation machinery (Eom et al., 2003; Pastalkova et al., 
2006). 
 
According to the theory of the posttranscriptional operon (Keene and Tenenbaum, 2002), 
different RBPs regulate subsets of mRNAs in a combinatorial manner and posttranscriptional 
regulation is determined by a code of multiple cis sequences in the untranslated regions of 
mRNAs. Comparable to polycistronic prokaryotic operons, monocistronic mRNA could mimic 
coordinated regulation of expression by interacting with distinct trans-acting proteins, 
which may act on subsets of mRNAs as a group or even regulate their own mRNAs.  
 
1.3 β-actin mRNA, an important localized transcript in neurons 
 
β-actin mRNA is a well studied example for transcripts that are localized and 
postranscriptionally regulated. Actin proteins need to be produced quickly and locally to 
establish cellular asymmetry. They polymerize into long filaments, pushing the cell’s 
membrane outwards, for example at the leading edge of migrating fibroblasts (Kislauskis et 
al., 1997) or in neuronal growth cones and dendritic filopodia (Bassell et al., 1998). The β-
actin isoform is particularly enriched in such dynamic structures, where cytoskeletal 
rearrangements take place. An explanation for the fact that this is the preferred isoform in 
remodeling processes could be its higher affinity to several actin binding proteins, which 
promote de novo nucleation, polymerization, uncapping or severing of filaments (Bassell et 
al., 1998). 
For the rapid sorting of these cytoskeletal components within cellular processes, the β-actin 
transcripts are transported as RNPs. As mentioned above, ZBP1 was shown to be involved in 
the localization of β-actin mRNA by binding to the 54-nt “zipcode” sequence in the β-actin 
3’-UTR (Hüttelmaier et al., 2005). It was shown that the formation of ZBP1 - β-actin mRNA 
complexes is necessary for its localization to growth cones, where local increases of β-actin 
concentration stimulate forward movement. Actin-dependent growth cone mobility could 
be enhanced in cultured chick neurons by administration of neurotrophin NT-3 and 
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impaired by β-actin 3’-UTR antisense oligos (Zhang et al., 2001). In the growth cones of 
Xenopus neurons, the localization of ZBP1 - β-actin granules depends on BDNF and Ca2+ 
signalling. Ca2+ may act on the balance of dephosphorylation and phosphorylation of targets 
to direct growth cone steering, and β-actin synthesis in growth cones is regulated by the 
asymmetric activity of Src kinases (Yao et al., 2006). 
Yet actin dynamics also play a major role in dendritic spine morphology, and actin 
modulates dendritic spines by tethering of PSD (postsynaptic density) - scaffold proteins to 
postsynaptic sites. Aberrant dendritic spine morphology has been related to disturbances in 
neuronal function such as dementia, thereby indicating a possible role in learning and 
memory (Sekino et al., 2007). ZBP1 knockdown in hippocampal cultures reduced the 
dendritic levels of β-actin mRNA and inhibited the growth of dendritic filopodia in response 
to BDNF treatment. Overexpression of β-actin-EGFP constructs increased the densitiy of 
filopodia and filopodial synapses, while the density of mature dendritic spines remained 
unaffected (Eom et al., 2003). Furthermore, F-actin (filamentous actin), consisting of β- and 
γ-actin, within the synaptic compartment is important in activity-dependent blockage of 
dendritic spine motility (Goetze et al., 2006). 
 
1.4 How is Staufen2 involved in the regulation of transported RNAs? 
 
Apart from ZBP1, another RBP was also implicated in β-actin mRNA localization, namely 
Staufen2. Like ZBP1, Stau2 (Staufen2) belongs to a family of evolutionarily conserved RBPs. 
Staufen was first described in Drosophila, where it is responsible for the localization of oskar 
mRNA to the posterior pole of oocytes and bicoid mRNA to the anterior pole, thus defining 
the body axis of the organism (Ephrussi et al., 1991). By localizing prospero mRNA in 
Drosophila neuroblasts, Staufen helps to obtain asymmetric divisions into neuroblasts and 
ganglion mother cells (Broadus et al., 1998). In Xenopus, Staufen was found to be involved in 
establishing polarity by transporting Vg1 mRNA to the vegetal pole of the oocyte (Yoon et 
al., 2004). The elements required for the formation of Staufen-containing RNA granules 
were first analyzed using the 3’-UTR of bicoid mRNA. An extensive stem-loop structure of 
the RNA was found to be necessary, but not sufficient, to bind Staufen, suggesting that 
there are additional targeting mechanisms. Staufen has 5 conserved double-stranded RNA-
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binding domains (dsRBDs), one of which is lost in mammalian Staufen (St Johnston et al., 
1992). These dsRBD-motifs recognize stem-loops non-specifically, yet the correct positioning 
of secondary structures of dsRNA and their interacting RNA-binding domains could 
potentially add a degree of specificity.  
There are two mammalian homologues of Staufen: Stau1, which is ubiquitously expressed 
and was mentioned above in the context of the Staufen-mediated decay pathway, and 
Stau2. Stau2 expression is largely restricted to the brain. It contains 4 dsRBDs, of which 
dsRBD3 is the major determinant for RNA binding, as well as a tubulin-binding domain, 
which may function as a link between the cytoskeleton and the RNA component (Wickham 
et al., 1999). 4 different isoforms of Stau2 are generated by alternative splicing, which range 
in size from 52-62kD. Only the two largest isoforms, Stau262 and Stau259 are imported into 
the nucleus and exported to the cytoplasm via exportin-5 and -1, respectively (Brownawell 
and Macara, 2002; Macchi et al., 2004; Kiebler et al., 2005, Miki and Yoneda, 2004). Thus, 
Stau2 could act as an adaptor protein for nuclear RNA export. Exportin-5 is also known as an 
export factor of miRNAs, suggesting a putative role of Stau262 and Stau259 in microRNA 
trafficking, yet distinct functions for the isoforms could not be distinguished so far. 
Mammalian Staufen colocalizes with the rough endoplasmatic reticulum and co-sediments 
with polysomes (Kiebler et al., 1999; Marion et al., 1999), which could indicate a possible 
role for Staufen proteins in translational control (Roegiers and Jan, 2000). 
Stau2-containing RNP complexes move along microtubules, using kinesin as a motor protein 
for their transport into dendrites, which appears to be modulated by neuronal activity 
(Jeong et al., 2007). They include, for example, poly(A)-mRNA, elongation factor 1α, 
ribosomal subunits, etc., yet the exact composition of these complexes seems to be variable 
(Kiebler and DesGroseillers, 2000; Kiebler and Bassell, 2006). 
Stau2 has been found in proximity of dendritic spines, marked by PSD-95, and its 
downregulation led to significant decreases of protrusions and PSD-95-clusters, as well as to 
reduced postsynaptic glutamate-receptor efficiency and mEPSC amplitudes. Likewise, Stau2-
downregulation affected F-actin levels in dendrites and diminished localized β-actin mRNA 
punctae in dendrites, while total actin levels remained unaltered.  Stau2 was shown to be 
required for the formation and morphogenesis of dendritic spines in cultured hippocampal 
neurons (Goetze et al., 2006).               
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1.5 Working hypothesis 
Definite RNA cargos of Stau2 remain to be confirmed, although Stau2 was recently 
suggested to be responsible for the dendritic localization of Map1b mRNA in hippocampal 
neurons (Lebeau et al., 2011). Yet the observed functional connection between Stau2 and 
the actin cytoskeleton proposes that Stau2 may interact with β-actin mRNA, influencing its 
stability, transport or translation. As reported by Goetze et al. (2006), downregulation of 
Stau2 in cultured mature hippocampal neurons (15 DIV) caused a reorganization of the actin 
cytoskeleton, which was shown by phalloidin stainings. In situ hybridization assays revealed 
that Stau2 knockdown also led to a reduction of β-actin RNA levels in both cell body and 
dendrites. Another consequence of Stau2 downregulation was a loss of mature dendritic 
spines, which start to form at 10 DIV in cultured hippocampal neurons, while the number of 
extended filopodia was increased.  
The expression of mammalian Stau2, which is brain-specific and changes over time, is 
detectable at all stages throughout neuronal development. In mature hippocampal neurons 
it was found only in the cell body and dendritic shaft, but -according to unpublished studies 
in the Kiebler lab- Stau2 is present in all neurites including the growing axon of young 
neurons. At stage 3 (2 DIV), Stau2 is detected in the axon and localizes within the F-actin rich 
periphery of the growth cone. Stau2 localization to growth cones is dependent on an intact 
actin cytoskeleton and is reduced after treatment with cytochalasin D, which disrupts the 
actin cytoskeleton. Since it is established that Stau2 affects β-actin mRNA levels and the 
localization of β-actin containing RNPs in mature neurons, the question arose whether Stau2 
would also be involved in the regulation of β-actin mRNA during development. Thus, the 
aim of my project was to further investigate the influence of Stau2 on the actin cytoskeleton 
in young hippocampal neurons and to unravel the molecular mechanisms underlying the 
regulation of its targets, focusing on β-actin mRNA.  
The putative interaction of Stau2 and β-actin mRNA may include effects on transcript 
stability, as for example seen in the Stau1 decay pathway, or the regulation of local 
translation, such as the temporary repression of β-actin synthesis by ZBP1. Although both 
ZBP1 and Stau2 could potentially be involved in the translation control and stabilization of 
mRNA, it remains to be discovered whether they play distinct or redundant roles. The 
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approach used in this study was to explore the possible effects on β-actin after 
downregulation of ZBP1 or Stau2. When successful downregulation with either siRNA 
oligonucleotides or short hairpin plasmids had been established, β-actin mRNA levels were 
examined by quantitative real-time PCR, while corresponding protein levels were analyzed 
by Western blot or immunostaining. To answer the question, whether Stau2 stabilizes β-
actin transcripts and/ or enhances their translation, RNA decay assays and luciferase assays 
were carried out. Luciferase reporters fused to part of the β-actin coding region displayed a 
slight increase of expression levels following Stau2 overexpression, whilst Stau2 
downregulation had minor opposite effects. As this could be explained by either enhanced 
translation or stability, RNA levels were measured after blocking RNA synthesis. Degradation 
of β-actin mRNA turned out to be augmented in hippocampal neurons with downregulated 
Stau2 levels. Taken together, I think that the experiments presented in this diploma thesis 
shed new light on the role of Stau2 in developing neurons and the molecular mechanisms of 
Stau2 in the regulation of localized RNAs.  
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II  Materials & Methods 
 
2.1   Materials 
 
2.1.1  Kits 
Wizard® SV Gel and PCR Clean-Up System - Promega 
EndoFree Plasmid Purification Kit - Qiagen 
Deoxyribonuclease I - Sigma 
First Strand cDNA Synthesis Kit - Fermentas 
iQ™ SYBR® Green Supermix - Bio-Rad 
GenElute Plasmid MiniPrep Kit – Sigma 
Dual-Luciferase® Reporter System – Promega 
Rat Neuron Nucleofector® Kit – Lonza 
Basic Neuron SCN Nucleofector® Kit - Lonza 
 
2.1.2  Reagents 
Acrylamide mix, 30% – Roth 
ActinomycinD, 95% - Sigma 
Agarose – Roth 
Ammonium peroxodisulfate (APS) - Roth 
Ampicillin – Sigma 
Bio-Rad Protein Assay - Bio-Rad 
Blocking Solution – Roche 
Bovine serum albumin (BSA) Calbiochem 
Chloroform – Fluka 
Detector Block, 5x KPL 
4',6-Diamidino-2-phenylindole dihydrochlorid (DAPI) - Roth 
Diethyl pyrocarbonate (DEPC) – Roth 
Dimethyl sulfoxide (DMSO) – Sigma 
Ethanol, absolute – Roth 
Ethanol, technical – Roth 
Ethidium bromide – Roth 
Formaldehyde, 37% – Merck 
Formaldehyde, 37% – Fluka 
Formamide (deionized) – Ambion 
FuGENE® HD Transfection Reagent – Roche 
Glycerol – Sigma 
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Guanidine hydrochloride - Sigma 
Isopropanol (2-Propanol) – Roth 
Isopropanol (2-Propanol) for molecular biology, min 99% - Sigma 
Loading Dye Solution, 6x – Fermentas 
Mowiol – Hoechst 
N,N,N’,N’-Tetramethylethylendiamin (TEMED) - Roth 
Paraformaldehyde – Merck 
Ponceau S – Merck 
RiboLock Ribonuclease Inhibitor (40 u/μl) – Fermentas 
RNase ZAP – Sigma 
Sodium acetate – Merck 
Sodium chloride – Merck 
Sodium dodecyl sulfate (SDS) 10% –Sigma 
Trichloric acid (TCA) – Merck 
Tris(hydroxymethyl)aminomethane (Tris) – Roth 
Triton X-100 – Sigma 
Trizol® Reagent - Invitrogen 
Tween 20 – Sigma 
 
2.1.3  Solutions and Media 
PBS (pH 7.4) 
137 mM NaCl 
10 mM Phosphate 
2.7 mM KCl 
 
Hank’s balanced salt solution (HBSS, pH 7.3) 
20 mM HEPES 
2mM CaCl2 
5.4 mM KCl 
1 mM MgCl2 
136 mM NaCl2 
1 mM Na2HPO4 
5.6 mM glucose 
ddH2O 
 
20x SSC (pH 7,0) 
3 M NaCl 
0,3 M Natrium-Citrat 
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B27-supplemented NMEM (NMEM-B27, pH 7.4) 
 
1x MEM (modified Eagle’s medium) from a 10x MEM stock 
26 mM NaHCO3 
1 mM sodium pyruvate 
200 mM L-glutamine, stable 
33 mM D-glucose 
2% B27 supplement 
ddH2O 
LB (for 1 l) 
10 g Tryptone 
5 g Yeast extract 
10 g NaCl 
ddH2O 
 
Lab blocking solution 
PBS  
2% fetal calf serum (FCS; PAA Laboratories, Pasching, Austria) 
2% BSA (Sigma) 
0.2% fish skin gelatine (Sigma) 
 
Annealing Buffer 
100 mM NaCl 
50 mM HEPES pH 7.4 
 
10x Blotting Buffer  
250 mM Tris 
1.92 M Glycine 
 
2x Laemmli Buffer (10ml) 
2.5ml 0.5M Tris HCl pH 6.8 
2ml 100% glycerol 
0.4g SDS 
3.1g DTT (0.2M) 
0.02% bromphenol blue 
ddH2O 
 
10x SDS Running Buffer  
0.25 M Tris 
1.92 M Glycine 
1% SDS 
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10x TBS  
150 mM Tris pH to 7.5 
1.5 M NaCl 
 
TBS-T  
1x TBS with 0.1% Tween 20 
 
50x TAE (2 L)  
484 g Tris 
114.2 ml Acetic acid 
200 ml EDTA (0.5 M, pH 8.0) 
pH to 7.5 to 7.8 with HCl 
 
1.5 mm 10% PA gel: 
 
- 5% Stacking gel (3ml) 
H2O 2.1 ml 
30% Acrylamide 500 µl 
M Tris (pH 6.8) 380 µl 
10% SDS 30 µl 
10% APS 30 µl 
TEMED 3µl 
 
- 10% Separation gel (10ml) 
H2O 4 ml 
30% Acrylamide 3.3 ml 
1.5 M Tris (pH 8.8) 2.5 ml 
10% SDS 100µl 
10% APS 100µl 
TEMED 4µl 
 
2.1.4 Enzymes 
Taq DNA polymerase (5 u/μl) – Fermentas 
DNaseI, RNase-free (1 u/µl) – Fermentas 
T4 DNA ligase (3 u/μl) – Promega 
T4 DNA ligase (5 u/μl) – Fermentas 
M-MuLV Reverse Transcriptase (20u/µl )- Fermentas 
 
2.1.5  Restriction enzymes 
BglII (10 u/μl) – Fermentas 
HindIII (10 u/μl) - Fermentas 
EcoR I (10 u/μl) - Fermentas 
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XhoI (10 u/μl) - NEB 
NotI (10 u/μl) – NEB 
 
2.1.6 Antibodies  
 
Antibodies for Western Blot 
Antibody dilutions for Western Blots were made in 1x Detector™ Block  
 
Primary antibodies 
Rabbit anti-Staufen2 (rabbit H7, 2007 – generated by D.Karra)  1:500  
Rabbit anti-ZBP1 (serum; S.Hüttelmaier)     1:600 
Mouse anti-Tubulin (monoclonal, Sigma)    1:5000 
Mouse anti-betaActin (monoclonal, Sigma)    1:1000 
Mouse anti-GAPDH (monoclonal, Sigma)        1:1500 
Secondary antibodies 
Donkey anti-rabbit 800 (LI-COR Biosciences, IRDye 800 – green)  1:10.000 
Donkey anti-mouse 700 (LI-COR Biosciences, IRDye 700 – red)   1:10.000 
 
Antibodies for Immunostaining 
Antibody dilutions were prepared in 10% Lab Blocking Solution in HBSS 
Primary antibodies 
Rabbit anti-Staufen2 (rabbit H7 or Hi4)    1:500- 1:300 
Mouse anti-ZBP1 (S.Hüttelmaier)     1:250 
Secondary antibodies 
Donkey anti-rabbit 488 (Invitrogen)     1:2000 
Goat anti-mouse Cy3 (Dianova)     1:2000 
 
Molecular staining 
Phalloidin 546 (Invitrogen)       1:500 
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2.1.7 Primers 
Primers for Realtime-PCR 
mRNA  Orientation Sequence Designed by 
GAPDH Gap-F-2 forward attcttccacctttgatgc Y.Xie 
Gap-R-2 reverse gtccaccaccctgttgctgta Y.Xie 
Tubulin Tub-F-2 forward tgtcttccatcactgcttcc Y.Xie 
Tub-R-2 reverse tgttcatggtaggctttctcag Y.Xie 
Staufen2 Stau2-F-2 forward gaacatctcctgctgctgaag Y.Xie 
Stau2-R-2 reverse atccttgctaaatattccagttgt Y.Xie 
Peptidylprolyl-
isomerase A 
(cyclophilin A) 
PPIA-for forward gtcaaccccaccgtgttctt S.Hüttelmaier* 
PPIA-rev reverse ctgctgtctttggaactttg  
18S rRNA 18S-for forward gttggtggagcgatttgtctgg S.Hüttelmaier* 
18S-rev reverse agggcagggacttaatcaacgc  
Vinculin VCL-for forward tcacagtggcagaggtagtg S.Hüttelmaier* 
VCL-rev reverse tgacagtgttcattgagttc  
β-Actin  Actb Short-
for 
forward gtccaccttccagcagatgt A.Konecna 
Actb S -rev reverse gaaagggtgtaaaacgcagc  
β-Tubulin Tubb-for forward ggaaagctgaggtgaaagg A.Konecna 
Tubb-rev reverse acaggcaacagtgaagagca  
γ-Tubulin Tubc-for forward gaggtggcttagagctgtct A.Konecna 
Tubc-rev reverse caggacagcaaatgcacagt  
Septin 7 Sept7-for forward aagcaaactgggaagctcaa A.Konecna 
Sept7-rev reverse tcaaacggatccaacaaaca  
γ-Actin Actg-for forward cttccagcagatgtggatca A.Konecna 
Actg-rev reverse ccagggaaatcgatacttc  
Zipcode-
Binding-
Protein1 
ZBP1-F- 2 forward atcatcggcaagaagggccagc
aca 
K.Wieczorek 
ZBP1-R-2 reverse gggtctggtctctcggcacga  
ZBP1-F-3 forward tcgtgccgagagaccagaccc S.Hüttelmaier* 
ZBP1-R-3b reverse ctgattcccactcattctca  
Firefly 
luciferase 
FFL-for forward gagtctatcctgctgcagcac L. Schoderböck 
FFL-rev reverse ctcgtccacgaacaccactc  
Renilla 
luciferase 
RNL-for forward gtccggcaagagcgggaatgg L. Schoderböck 
RNL-rev reverse acgtccacgacactctcagcat  
Table 2.1.1 Realtime PCR Primers (all primers were ordered from Sigma) 
*Primer sequences from S.Hüttelmaier (unpublished, 2009) were adapted from homo 
sapiens to rattus norvegicus 
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Colony PCR primers 
 
 Orientation Sequence 
pSUPER2101f forward acacaggaaacagctatgac 
pSUPER-2390rv reverse gcgccctggcaggaagatgg 
Table 2.1.2 Colony PCR Primers 
 
2.1.8 Plasmids 
 
insert vector backbone lab plasmid list nr° 
 pEGFP-C2 215 
Staufen2-EGFP pEGFP-C2 169 
EGFP-ZBP1 pEGFP-C2 240 
 pSuperior.neo+GFP 100 
shStau2 pSuperior.neo+GFP 181 
misStau2 pSuperior.neo+GFP 182 
shStau2 pSuperior.neo+GFP 403 
shNon-targeting  pSuperior.neo+GFP 410 
shZBP1 pSuperior.neo+GFP 404 
psiSTRIKE shIMP1 psiSTRIKE U6 hairpin 469 
psiSTRIKE shIMP1 scrambled psiSTRIKE U6 hairpin 471 
 psi-CHECK 2 435 
Limk1 3'UTR FL psi-CHECK 2 437 
human β-Actin 3´UTR psi-CHECK 2 444 
human β-Actin zipcode psi-CHECK 2 445 
human β-Actin coding region+ 
zipcode 
psi-CHECK 2 446 
 Table 2.1.3 Plasmids 
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Fig. 2.1.1  pSuperior.neo+GFP map from www.oligoengine.com 
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2.1.9 Marker 
GeneRuler™ 1 kb DNA Ladder (0.5µg/µl)         GeneRuler™ 100 bb DNA Ladder 
(0.5µg/µl) 
 – Fermentas                            -  Fermentas 
 
       
 
PageRuler™ Prestained Protein Ladder – Fermentas 
 
  
 
Fig 2.1.2 – http://www.fermentas.com 
 
 
2.1.10 Equipment 
Thermomixer compact, Eppendorf  
Vortex VF2 Janke & Kunkel IKA  
pH Meter MP 225, Mettler Toledo  
Shaker, GFL 3015  
Waterbath, GFL  
 
Materials & Methods 
32 
 
Incubator, shaking, INFORS, Unitron  
Incubator, kelvitron t, Heraeus  
Balance, KERN ABS  
Balance, KERN 440-49N  
GeneQuant 100 Spectrophotometer – GE Healthcare 
GloMax® 96 Microplate-Luminometer - Promega 
Cuvette Suprasil, 10 mm, Hellma  
Power Pac 300 power supply for electrophoresis, BIO-RAD  
Power Pac HC power supply for electrophoresis, BIO-RAD  
Mini-Protean® 3 Cell SDS-PAGE-System, BIO-RAD  
Nucleofector® - Lonza  
Trans-Blot Cell blotting chamber, BIO-RAD  
Odyssey® Infrared Imaging System - LI-COR® Biosciences; software: Odyssey® Application 
Software 2.1 
C1000 Thermal Cycler– BIO-RAD 
Peqlab imaging system with UV/IR interference filter type F590 or SYBR® photographic 
filter  
Centrifuge 5417 C Eppendorf  
Centrifuge 5417 R Eppendorf  
Virifuge 3.OR Heraeus  
Rotor Heraeus #8074  
Centrifuge AvantiTM J-25, Beckman Coulter  
Rotor JLA 10.500, Beckman  
Rotor JA 25.50, Beckman  
Ultracentrifuge OptimaTM TXL, 120000 rpm, Beckman Rotor TLA 100.3, Beckman with 
polycarbonate centrifuge tubes, 13x51 cm, Beckman  
Molecular Imager® FX (+ Screen Eraser – K), BIO-RAD  
MyiQ™ Single Color Real-Time PCR Detection System - BIO-RAD; software: iQ5 Optical 
System Software (Version 2.0) - BIO-RAD 
Leica MZ 16F - Leica; software: Leica Application Suite  
Axioplan - Zeiss; software: analySISB - Olympus 
 
Software: 
– AnalysisB, Soft Imaging System 
– LaserGene version 8.0, DNASTAR 
– Metamorph version 7.0, Molecular Devices 
– MS Office Excel 2003, Microsoft 
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2.2  Methods 
 
2.2.1 Cloning  
2.2.1.1  Cloning of shRNA Plasmids  
 
 
Fig. 2.2.1 (©http://www.oligoengine.com) 
To create short hairpin RNA vectors for the specific suppression of gene expression through 
RNA interference, the pSUPERIOR.neo+gfp vector from the pSUPER RNAi SystemTM from 
OligoEngine (Brummelkamp, T. R. et al. 2002) was used.  
In this vector a polymerase-III H1-RNA gene promoter produces siRNA-like transcripts with 
a start of transcription and a termination signal consisting of a stretch of five thymidines 
(T5). Subsequent cleavage of the transcript at the termination site after the second U leads 
to the formation of a mature siRNA with an overhang of two uridine nucleotides at the 
3’end.  
The oligonucleotides for the silencing of a specific gene contain a unique 19-nt sequence 
complementary to a sequence within the target mRNA. For cloning into pSUPERIOR, two 
complementary oligos were designed: the forward oligo includes the 19-nt target sequence 
in both sense and antisense orientation. There is a 9-nt spacer sequence in between, while 
the ends are flanked by sequences corresponding to sites of the restriction enzymes HindIII 
and BglII, and the 3’ end also contains the T5 sequence (see Fig 2.2.1.). Upon ligation, the 
overhang sequence of the oligo destroys the BglII site to facilitate the screening of positive 
clones. The resulting transcript is supposed to fold back on itself to create a 19–base pair 
stem-loop precursor transcript, which is processed into the mature siRNA duplex, the 
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antisense strand of which is able to hybridize to the target mRNA to mediate its cleavage. A 
targeting sequence with a single mismatch should not affect expression of the target gene 
(Brummelkamp, T. R. et al. 2002) and is therefore suitable as a negative control. 
All primer pairs were designed according to the manufacturer’s protocol and ordered from 
Sigma-Aldrich. After annealing of the 60-nt oligos, they were cloned into the linearised 
pSUPERIOR.neo+gfp vector. While the EGFP expression of this vector served as an indicator 
of transfection efficiency in mammalian cells, the ampicillin resistance conferred by the 
plasmid was used for selection of E. coli clones after transformation. 
Primer annealing 
1µl of both the forward and reverse primer, diluted to 3µg/µl in ddH2O, were added to 48 
μl Annealing Buffer (100 mM NaCl, 50 mM HEPES pH 7.4) and heated at 90°C for 4 min in 
the PCR cycler, then cooled down to 37°C in successive steps. 
 
PCR cycler program for primer annealing: 
94 °C 4 min   
90 °C 4 min   
85 °C 4 min   
80 °C 4 min   
70 °C 4 min   
60 °C 4 min   
50 °C 4 min   
37 °C 10 min   
4 °C forever   
The annealed primers were directly used in a ligation reaction or stored at -20°C. 
 
Ligation with pSuperior 
To insert the primer sequence into pSUPERIOR, the vector was linearised with HindIII and 
BglII and ligated with the annealed primer mix with aid of a T4 DNA ligase, which is able to 
join blunt or sticky ends of dsDNA. 1µl of the vector (0.5µg/µl) and 2µl of the annealed 
primers were combined with 1µl 10x T4-Ligase Buffer (400 mM Tris-HCl, 100 mM MgCl2, 
100 mM DTT, 5 mM ATP; Fermentas), 5µl nuclease-free H2O and 1µl T4 DNA Ligase (5 u/µl, 
Fermentas). This mixture was incubated for 2h at RT.   
Digestion with BglII  
As the BglII restriction site in the vector is destroyed upon successful cloning of the primer 
pair, plasmids containing the insert will not be cut by this enzyme any more. Thus a BglII 
digestion step before transformation could be used to reduce the background of false-
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positive clones, because the enzyme would only digest self-ligated pSUPERIOR vectors. The 
ligation reaction was incubated with 1μl BglII enzyme (Fermentas) for 30 min at 37°C. 
 
2.2.1.2 Subcloning from pre-existing vectors  
 
Restriction digestion 
 
To transfer a sequence from one vector into another one, the sequence has first to be 
excised from its plasmid. For example, to clone β-actin sequence fragments from pGEM-T 
to psiCheck2, they were cut out by a double digestion with the enzymes XhoI and NotI 
(New England Biolabs). 1.5µl of each enzyme were added to 0.5µl BSA and 5µl 10x Buffer 3 
(NEB; a buffer was chosen, in which both restriction enzymes had the highest activity) and 
filled up with plasmid DNA from a miniprep to a total volume of 50µl, before incubation at 
37°C for 2 hours. After that the DNA was separated on an agarose gel to identify and 
isolate the fragment. 
 
Agarose gel electrophoresis 
 
For the separation of DNA fragments of a few hundred kb or larger, a 1% gel was prepared 
by dissolving 1g of agarose in 100ml 1x TAE buffer by heating in the microwave. For shorter 
DNA sequences, 1.5% to 2% gels were prepared accordingly. The solution was cooled down 
under constant stirring before 50μl of ethidium bromide were added per 100ml. 
Afterwards the gel was poured and left to polymerize at RT. DNA samples were combined 
with 6x loading dye (usually 25µl sample + 5µl loading dye) and loaded on the gel together 
with 10µl of a size marker, such as a 1kb DNA ladder (Fermentas) or a 100bp DNA ladder 
(Fermentas) for small fragments. The gel was run in 1x TAE buffer at 100 V until bands were 
sufficiently separated. 
 
Gel elution  
 
Following electrophoresis, the DNA band of the predicted size was cut out and purified 
using the Wizard® SV Gel and PCR Clean-Up System (Promega) according to the 
manufacturer’s protocol. The bands were excised from the agarose gel with a clean scalpel 
blade under UV light and transferred to a 1.5ml tube. After weighing the gel slices, 1µl of 
Membrane Binding Solution were added per 1mg of gel slice, then they were vortexed and 
and heated at 55°C until the gel had dissolved. The solution was transferred to a 
Minicolumn in a collection tube, incubated at RT for 1 min to allow DNA binding and 
centrifuged for 1 min at 16,000g. After washing the membrane twice with Membrane 
Wash Solution, the DNA was eluted with 50µl nuclease-free water by centrifugation, and 
either used immediately in a ligation reaction or stored at -20°C. 
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Ligation 
 
1µl of the vector was combined with 3µl of the purified insert, 5µl 2x T4-Ligase Buffer 
(Promega) and 1µl T4 DNA Ligase (3 u/µl, Promega), before it was incubated for 2h-3h at 
RT.   
 
Transformation 
 
100 μl of Top10 E. coli competent cells were thawn on ice and mixed carefully with 2 μl of 
ligation mix. We used TOP 10 –chemically competent E.coli (Invitrogen; Genotype: F´ mcrA 
Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1araD139 Δ(ara-leu)7697 galU galK rpsL 
endA1 nupG). After the mixture was incubated on ice for 30 min, a heat shock was 
performed in a water bath at 42°C for 1 min, to make possible that the cells take up DNA. 
Then the cells were again cooled on ice for 2 min before incubation with 700 μl LB medium 
for 1h at 37°C, shaking at 400 rpm. During this step of bacterial growth, cells can develop 
resistance against the antibiotic used for selection. Afterwards the cells were pelleted at 
4,000 rpm for 5 min, 700 μl of the supernatant were removed and the pellet was 
resuspended in the remaining 100 μl LB medium. This cell suspension was plated on LB- 
agar plates containing the suitable antibiotic and incubated at 37°C overnight. 
 
Miniprep 
 
5 ml LB medium containing the suitable antibiotic were inoculated with a transformed 
colony and incubated overnight at 37°C shaking at 225rpm. The culture was transferred 
into two 2ml tubes and bacteria were pelleted at 4,000 rpm for 5 min in a microcentrifuge. 
Then lysis of the cells and the isolation of plasmid DNA were performed using GenElute 
Plasmid MiniPrep Kit (Sigma) according to the manufacturer’s protocol. The DNA was 
eluted from the columns with 50μl nuclease-free H2O. 
 
Test-digestion  
 
To verify, that the plasmid DNA from the picked clone contains the insert, the DNA 
obtained from a miniprep can be used in a test digestion. In the case of pSuperior, 1µl of 
the purified plasmid was cut with 0.75µl of both of the restriction enzymes HindIII and 
EcoRI in 15.5µl ddH2O and 2µl BamHI-buffer (Fermentas; chosen with the aid of the 
Fermentas Double Digest™ Engine). The mix was incubated for 2 hours at 37°C and 
examined by gel electrophoresis. Whilst fragments cut out from negative clones would be 
227 bp long, those containing the insert would have 281 bp. 
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Maxiprep 
Positive clones containing desired insert were inoculated in 200 ml LB medium with the 
appropriate selection antibiotic (100μg/ml) and incubated at 37°C and 225rpm overnight. 
On the next day, 1ml of the bacterial culture were transferred to a cryotube and combined 
with 0.5 ml glycerol. This glycerol stock was kept at -80°C as a backup.    
Plasmid DNA was prepared from the cultures using the EndoFree Plasmid Purification Kit 
(Qiagen). This method yields high concentrations of endotoxin-free plasmid DNA, which is 
necessary for the successful transfection of hippocampal neurons (Zeitelhofer, M. et al. 
2008). Endotoxins are bacterial components that are highly cytotoxic for neurons. Cells 
were pelleted by centrifugation at 6,000 g and 4°C for 15 min (Avanti J-25TM Centrifuge -
Beckman Coulter, rotor JLA10.500). The following isolation of plasmid DNA was performed 
as described in the manufacturer’s protocol, with the exception that the eluted and 
precipitated DNA was washed twice with 70% ethanol and centrifuged at 20,000g and 4°C 
for 5min at the end of the procedure. The washed DNA pellet was dissolved in 180µl 
endotoxin-free H₂O. The DNA concentration was measured by UV spectrophotometry at a 
wavelength of 260 nm, and the purity of the sample was also examined by using the 260 
nm: 280 nm ratio, which should be above 1.6 for samples free of substantial protein 
contamination. The isolated DNA was then aliquoted and stored at -20°C. 
 
Colony PCR 
 
Colony PCR was performed to identify transformed clones that contain a plasmid with the 
desired insert. Therefore single colonies were picked from the original plate with a sterile 
pipette tip. From each colony a streak was made onto an LB plate with the respective 
antibiotic and marked by numbers, and then the same tip was used to resuspend the rest 
of the colony in 25µl of the PCR reaction mix.  
 
Reaction mix: 
2.5 μl 10x Taq buffer 
1.5 μl 25 mM MgCl2 
0.5 μl dNTPs (10 mM for dATP, dCTP, dGTP, dTTP) 
0.7 μl 3’-Primer (forward pSuperior) 
0.7 μl 5’-Primer (reverse pSuperior) 
0.2 μl Taq polymerase (5 u/μl, Fermentas) 
18.9 μl ddH2O 
25µl total volume 
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PCR program: 
94°C 60s  1 cycle 
94°C 30s 
47°C 30s           30 cycles 
72°C 60s 
4°C forever 
 
After the PCR, 5 μl of a 6x Loading Dye (Fermentas) were added to each sample and the 
total reaction volume was loaded on a 2% agarose gel, together with 12 μl of a 100 bp DNA 
Ladder (GeneRulerTM, Fermentas) and a positive control, for example the PCR reaction from 
an empty vector (with pSuperior added instead of a picked colony). After running the gel, 
pictures of the gel were taken using UV imaging. 
In the case of the pSuperior-plasmids, several colonies were picked and tested with primers 
specific for the pSuperior vector sequence surrounding the insert (for primer sequences see 
Table 2.1.1). Amplified fragments from the vectors containing the desired inserts were 
60bp longer and therefore running above the empty vectors on a gel. The identified 
positive clones could then be picked from the plate and were used to inoculate LB for an 
overnight culture for Minipreps to confirm the result by test digestions. 
 
2.2.2 Cell Biology Methods 
 
Hippocampal Cultures 
 
Hippocampal neurons were derived from E17 (embryonic day 17) embryos from rattus 
norvegicus as described in Zeitelhofer et al. (2007). Dissection of the hippocampi and 
preparation of hippocampal cells was carried out by Sabine Thomas, Krzysztof Wieczorek, 
Julia Riefler, Samantha Herbert and Kristina Kosenburger. 
 
Preparation of Cortical Cultures 
 
The whole procedure was carried out under sterile conditions, all solutions and media were 
pre-warmed to 37°C. The dissected cortices of E17 embryos (without hippocampi) in HBSS 
were cut up as small as possible with clippers in a petri dish and then transferred into a 
falcon tube. After centrifugation at 1000rpm for 4 min, the HBSS was removed and pre-
warmed trypsin was added.  For 10 min the brain tissue was incubated with trypsin in a 
waterbath at 37°C to disrupt cell-to-cell and cell-to-membrane contacts, before medium 
(DMEM+horse serum) was added to inactivate the trypsin. Again cells were centrifuged at 
1000rpm for 4 min, trypsin was sucked off and 6ml DMEM+HS were added. To dissociate 
the cells, the solution was first pipetted with blue tips, and then triturated with “fire 
polished” Pasteur pipettes for approximately 1 min. The cells were subsequently filtered 
four times through cell sieves of two different pore sizes (70µm- and 100µm- cell strainers) 
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and diluted with medium to a volume of 25ml. Cell numbers were determined with the aid 
of a counting chamber, then cells were ready for plating or transfection. 
 
HeLa cells 
 
HeLa cell cultures (HeLa cells obtained from DSMZ Heidelberg) were usually split 1:10 
approximately every 3 to 4 days at 80-90% confluence. A flask with 15ml DMEM+FCS was 
equilibrated in an incubator at 37°C and 5% CO₂ for at least 2 hours, before the cells were 
split. Confluently grown cells were washed with pre-warmed PBS and incubated with 2ml 
trypsin for 1 min at 37°C.  After the excess trypsin was removed, the attached cells could be 
released by tapping the flask and were resuspended in 10ml DMEM+FCS, of which 1ml was 
transferred to the new flask.  
 
Nucleofection 
 
Nucleofection is a method of direct electroporation of expression plasmids into the nucleus 
of mammalian cells ensuring high transfection rates and good cell viability even in 
postmitotic cells, such as neurons, which are sensitive to mechanical stress and cytotoxic 
components and diffcult to transfect. In contrast to other transfection methods suitable for 
neurons (e.g. CaPO-coprecipitation), nucleofection is efficient enough to yield enough 
material for biochemical analysis, such as Western blotting or realtime-PCR. 
Immediately after the preparation of cortical or hippocampal rat neurons from E17 rat 
embryos, they were transfected with the Amaxa™ Nucleofector using the O-003 program, 
as described in Zeitelhofer et al. (2009). Either the Rat Neuron Nucleofector® Kit (Lonza) or 
the Basic Neuron SCN Nucleofector® Kit (Lonza) for small cells numbers were used. The 
neurons were then incubated at 37°C and 5% CO2. 
 
Calcium-Phosphate Transfection of Hippocampal neurons 
 
The transfection of hippocampal neurons with plasmid DNA using CaPO-coprecipitation 
was carried out as described in Goetze et al. (2004). 
 
Transfection of HeLa cells using FuGENE™- HD Transfection Reagent 
 
One day before lipofection with FuGENE™ HD Transfection Reagent (Roche), 75,000 HeLa 
cells were plated per well in a 24-well-plate with DMEM + FCS. At a confluency of 80-90%, 
the cells were washed with pre-warmed PBS, then 500µl OPTI-MEM™, a serum-free 
transfection medium, were added to each well. While cells were in the incubator (37°C, 5% 
CO2), a mixture of FuGENE™ reagent and DNA at a ratio of 5:2 was prepared. 0.5µl reagent 
were added to 0.2µg DNA (0.1 µg of the luciferase reporter plasmid and 0.1 µg of the 
overexpression plasmid) and mixed with 25µl OPTI-MEM medium per well. The mixture 
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was vortexed briefly and incubated for 15 min at RT, before it was added drop-wise into 
the wells. After 5-6 hours at 37°C the transfection medium was replaced by DMEM + FCS. 
24 hours later cells were lysed and used for luciferase assays. 
 
Accell® siRNA 
 
Accell oligos from Dharmacon were used for the silencing of target genes by RNA 
interference. The Accell siRNAs are 18-30nt long duplex oligonucleotides, which are 
coupled to a cholesterol moiety via an alcohol-amine linker region. Thereby these 
molecules are capable of entering cells without an additional delivery procedure. To confer 
greater stability to the oligonucleotide complexes, chemical modifications have been 
added to some or all of its C and U nucleotides as well as to the first two nucleotides of the 
5’ end, such as 2’-O methyl or 2’-F modifications. The antisense strand contains a 2 
nucleotide overhang at the 3’ end, and it is complementary to the target gene. 
Accell siRNA was resuspended in 1x Dharmacon siRNA Resuspension Buffer according to 
the manufacturer’s instructions and stored at -80°C in small aliquots, to avoid repeated 
freeze-thaw-cycles. Accell siRNA was added directly into the cell culture medium 
(NMEM+B27; the Accell delivery medium, which is a serum-free medium especially 
formulated for siRNA delivery, was not used due to cytotoxic effects on neurons), either at 
0DIV (days in vitro) or at 3DIV. Accordingly, 5µl siRNA solution from the 100µM stock were 
added per 1ml medium, yielding a final concentration of 0.5µM. Cells were incubated at 
37°C and 5% CO2 as usual, after 48 hours the medium was partially exchanged with fresh 
NMEM+B27. 72 to 96 hours after addition of the oligonucleotides, the cells were harvested 
and RNA and/or proteins were isolated. 
 
 
Accell oligos Target sequences 
siRNA Staufen2 
(Set of 4 siRNAs) 
siSTAU2 #13 cuuuuauguucaguugacu 
siSTAU2 #14 ccgucaguuuugagguuau 
siSTAU2 #15 gccauagguuuaaaaggaa 
siSTAU2 #16 cgaguauggucaaggaaug 
siRNA ZBP1 
(Set of 4 siRNAs) 
siZBP1 #13 cuccaaaguucgaaugguu 
siZBP1 #14 uuguuaagaucaucggaca 
siZBP1 #15 uugcggagcacaagaucuc 
siZBP1 #16 ccugaagguuuccuacaua 
negative control Non-targeting siRNA uaaggcuaugaagagauac 
positive control GAPDH siRNA  
transfection control FAM-labeled Non-targeting 
siRNA 
uaaggcuaugaagagauac 
Table 2.2.1 Accell oligos 
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Immunocytochemistry & Microscopy 
 
HBSS and paraformaldehyde (PFA) were prewarmed to 37°C. Cells on coverslips were 
briefly rinsed with HBSS and fixed in 4% PFA in HBSS for 15 min. After washing with HBSS, 
cells were permeabilized using 0.1% Triton X-100 for 5 minutes. After another washing 
step, the coverslips were blocked by addition of the lab blocking solution for 30 min at RT. 
Then they were incubated with solutions of one or two antibodies diluted in 10% blocking 
solution in HBSS. After 1.5 - 2 h at RT or overnight at 4°C, the coverslips were washed in 
HBSS three times for 5 minutes while shaking. The corresponding secondary antibodies 
were applied for 45 min at RT in the dark. They were linked to a fluorophore and reacted 
with primary antibodies which were derived from a different organism, thereby leading to 
visualization of the bound primary antibody. After washing with HBSS as previously, the 
coverslips were incubated in DAPI solution for 3 min in the dark for nucleic staining. Finally, 
the cells were washed in HBSS again, then dipped briefly into ddH2O and mounted with 7µl 
Mowiol onto objective slides, cells facing downwards. 
 
The stained cells were subsequently examined using an Axioplan microscope (Zeiss). 
Pictures of the cells were taken with analySISB software (Olympus) and adapted with 
Adobe Photoshop. 
 
2.2.3 Quantification of RNA-levels 
 
RNA isolation with TRIzol® 
 
The TRIzol® Reagent is a mono-phasic solution of phenol and guanidine isothiocyanate, 
which breaks up cells and dissolves cell components, while protecting the RNA. Samples 
containing TRIzol® Reagent were handled under a chemical fume hood. 
 
The medium was removed and cells were washed briefly with PBS pre-warmed to 37°C, 
before they were resuspended in 1ml TRIzol® Reagent per dish by pipetting up and down. 
The suspension was transferred into a sterile, RNase-free Eppendorf tube and incubated 
for 5 min at RT. After adding 0.2 ml chloroform, the solutions were mixed thoroughly by 
inversion and incubated at RT for 3 min before being centrifuged at 12,000 g and 4°C for 15 
min. After centrifugation the aqueous phase containing the RNA had separated from the 
organic phase and was transferred into a fresh tube, mixed with 0.5 ml isopropanol and 
incubated for 10 min at RT. After that the RNA was precipitated by centrifugation at 12,000 
g and 4°C for 10 min. The supernatant was discarded and the RNA pellet was washed with 
1 ml 75% ethanol. Following centrifugation at 7,400 g and 4°C for 5 min, the RNA pellet was 
air-dried for 10 min. Afterwards the RNA was resuspended in 15µl DEPC-treated water and 
shaken in the thermomixer at 50°C and 350rpm  for 10 min. Total RNA in DEPC-treated 
water was stored at -80°C. 
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The concentration of RNA was determined by UV spectrophotometry at 260 nm. 1:100 
dilutions were prepared for the measurement. The purity of the sample from protein 
contamination was represented by the 260 nm: 280 nm ratio, which was usually above 1.6.  
  
To avoid RNase contamination, gloves were worn at all times and both gloves and working 
space had been cleaned with ethanol and RNaseZAP® (Sigma®). Only water treated with 
0.1% diethylpyrocarbonate (DEPC) as well as RNA grade chemicals were used to prepare 
solutions. Also, barrier tips and RNase-free tubes (Eppendorf) were used for RNA 
experiments. 
 
DNAse digestion  
 
To reduce DNA contamination after RNA isolation, samples were treated with DNase 1 
(Fermentas). 0.5 - 1µg of RNA were diluted with DEPC-treated Water to a volume of 8µl. 
After adding 1µl of 10X DNase I reaction buffer with MgCl2 and 1µl of RNase-free DNase I, 
the mix was incubated 30-60 min at 37°C. To stop the digestion, 1 μl of 25 mM EDTA was 
added and samples were incubated for 10 min at 65°C. Then the RNA could be directly 
used in the cDNA synthesis reaction. 
 
cDNA synthesis 
 
CopyDNA was generated for the analysis of the template mRNA because DNA is much 
more stable than RNA. Reverse transcription of total RNA into cDNA was performed using 
Moloney Murine Leukemia Virus Reverse Transcriptase (M-MuLV), an RNA- and DNA-
dependent DNA polymerase from the First Strand cDNA Synthesis Kit (Fermentas) 
possessing ribonuclease H activity specific to RNA in RNA-DNA hybrids. 
0.5 - 1 μg total RNA in DEPC-H₂O, in a total volume of 11µl after DNase-treatment, were 
combined with 0.5µl random hexamer primers and 3.5µl DEPC-H₂O. To denature RNA 
secondary structure within the template, the mix of RNA and primers was heated at 70°C 
for 5 min and then chilled on ice for 5 min to let the primer anneal to the RNA.  
Afterwards 10µl of a mastermix were added to each template, which consisted of the 
following reagents: 
 
5 μl 5X M-MuLV RT Reaction Buffer  
1.25 μl dNTPs (10 mM for dATP, dCTP, dGTP, dTTP) 
1.25 μl RiboLockTM Ribonuclease Inhibitor  
1.5µl DEPC-H₂O 
1 μl M-MuLV Reverse Transcriptase (20 u/μl; Fermentas)  
 
As a control for potential contamination with genomic DNA, 1.5µl DEPC-H₂O was added 
instead of reverse transcriptase.  
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The reaction mix then had a total volume of 25µl and was incubated in the PCR cycler:  
- 10 min 25°C 
- 50 min at 42°C 
- 15 min at 70°C (to inactivate the enzyme) 
 
Quantitative real-time PCR 
 
Real-time PCR was performed for the quantification of specific RNAs, after total RNA had 
been reverse transcribed into cDNA. As DNA is amplified exponentially in the early and 
middle cycles of a PCR, this allows for the amount of template to be deduced. During a 
real-time PCR run, the generation of product is constantly monitored by the detection of 
fluorescence. Consequently a dye has to be present in the reaction mix, like SYBR Green, 
that intercalates double-stranded DNA and emits fluorescence, the intensity of which being 
proportional to the quantity of DNA present in the reaction.  
 
The PCR cycler MyQ iCycler (BioRad) with iQ5 Optical System Software 2.0 and the iQ SYBR 
Green Supermix (BioRad) were used for real-time PCR experiments. 2x SYBR Green 
Supermix contains 100 mM KCl, 40 mM Tris-HCI (pH 8.4), 0.4 mM of each dNTP (dATP, 
dCTP, dGTP,and dTTP), iTaq DNA polymerase (50 u/ml), 6 mM MgCl₂, SYBR Green I, 20 nM 
fluorescein, and stabilizers. The fluorescein dye in this mixture is used for internal 
calibration. The iTaq DNA polymerase is a hot-start enzyme which is inactive at RT and has 
to be activated with an initial 3 min denaturation step at 95°C. 
 
For each primer pair a mastermix was prepared, usually with a final primer concentration 
of 300 nM and the standard MgCl₂ concentration of 3 mM. 
 
1x reaction mix for real-time PCR: 
12.5µl  2x iQ SYBR Green Supermix 
1.5µl forward primer (5 µM) 
1.5µl reverse primer (5 µM) 
ddH₂O 6.5µl____ 
22µl total 
 
To this mixture 3 µl of cDNA dilution were added into each well of a 96-well-plate. 
Triplicates were measured for each sample. The template cDNA was usually diluted 1:10 
with nuclease-free H₂O, except for cases where primers were specific for particularly rare 
or abundant transcripts. For example, for the amplification of the very abundant 18S rRNA, 
the template was usually diluted 1:100 to be in a comparable range. For the “no template 
control” (NTC), 3 µl ddH₂O were added into the well instead of cDNA. Any signal detected 
from this well would hint at a contamination of reagents with nucleic acids or the 
formation of primer-dimers. To check for genomic DNA within the template, a “no enzyme 
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control” (NEC) was applied, where reverse transcriptase had been omitted during cDNA 
synthesis.  
 
Finally the 96-well plates were sealed with Flat Cap Strips (Bio-Rad) to prevent evaporation.  
 
PCR cycle scheme: 
- 95°C for 3 min  
- 95°C for 10 sec       
- 55°C for 30 sec              40x 
Melting curve: 
- 55°C to 95°C (+0.5°C per cycle) for 30 sec/ step  - 81x 
At the end of the amplification cycles, a melting curve analysis was performed, in which the 
temperature was raised by 0.5°C every 30s. At the melting point, the DNA strands 
dissociate and the fluorescence rapidly decreases. The melting temperature (Tm) is 
characteristic for a DNA double helix and depends on its length and base composition. As 
all fragments amplified with the same primers should show fluorescence peaks at relatively 
identical temperatures, melting curve analysis can be applied as a quality control for real-
time PCR reactions, to make sure that only one specific product is amplified and detected. 
Different melting curves from the same sample hint at DNA contamination, primer-dimer 
artifacts, annealing of primers to non-target DNAs, etc. 
Primers for qPCR were designed to meet certain criteria, for example that the amplified 
region should not exceed 200-300bp. Also, primers should have a length of approximately 
20 nucleotides and, if possible, they should span an exon-exon boundary or the primer pair 
should be separated by an exon-exon boundary, to reduce genomic background (for primer 
sequences, see table 2.1.1). 
To confirm that primers work properly, a standard curve real-time PCR was performed for 
every primer pair. With the aid of this step efficiency of the PCR reaction, R2 and slope 
values can be monitored. The conditions of the reaction, usually MgCl2 and/or primer 
concentration, have to be optimized in a way that the efficiency of the PCR is in a range of 
85-100%, the R2 coefficient close to 1 and the slope in a range of –3.1 to –3.6.  For 
standard curve reactions, cDNA from brain lysate or untransfected cells was used from 
which dilution series were prepared in 10-fold steps, ranging from 1:10 to 1:10.000.  
 
Evaluation of all PCR results was done according to the comparative ΔΔCt (delta-delta Ct) - 
method (Schmittgen T. and Livak K., 2008). The cycle threshold (Ct) is a baseline set in the 
logarithmic range of DNA amplification. This is usually at the beginning of the intensity 
curve, where the increase of fluorescence is exponential. To calculate the relative amounts 
of a gene of interest, its Ct-value is normalized to the Ct-value of an internal control and 
compared between two different samples, for example treated and untreated samples or 
samples transfected with an overexpression vector and such transfected with the empty 
vector, etc. 
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2 –ΔΔCt = [(Ct gene of interest - Ct internal control) sample A – (Ct gene of interest - Ct 
internal control) sample B] 
 
One of the drawbacks of this quantification method is that it only yields relative results and 
depends highly on the choice of reference genes. Also, it assumes that primers for 
unknown and reference gene have identical efficiency.  
Normalization of the qPCR data to a single reference gene is not recommendable, as even 
the expression of so-called housekeeping genes, like GAPDH or Tubulin, is occasionally not 
completely constant across different conditions, which will skew the results. Therefore, the 
gene of interest was always analyzed together with a set of several reference genes and 
evaluated by internal cross-normalization (Weidensdorfer et al., 2009). Therefore ΔΔCt- 
values of the gene were calculated for each control and then averaged, outliers having 
been removed. 
 
RNA agarose gel electrophoresis 
 
To assess the quality of the isolated RNA, RNA gel electrophoresis on a 1.5% agarose gel 
was performed. As a precaution against RNase-contamination, RNA gel electrophoresis was 
carried out using special equipment, as RNase-free pipettes or barrier tips, and at a 
working space reserved for RNA work.  
1.5 g agarose (top-vision, RNase-free) were dissolved in 73ml DEPC-treated water, heated 
in the microwave and cooled down to approx. 55°C under cold tap water. 10ml 10x MOPS 
electrophoresis buffer and 17ml 37% formaldehyde were added under a chemical fume 
hood, before the gel was poured into the tray, which had been soaked in 0.2M NaOH 
before for 60min. 
 
A sample of 1 μg of RNA diluted in 6 μl DEPC water was denatured by adding a mixture of 
12.5μl of formamide, 2.5µl 10x MOPS and 4µl 37% formaldehyde. Then samples were 
heated at 65°C for 10 min, after that they were chilled on ice and 2.5μl RNA loading dye 
mix was added.  
First the gel was pre-run in 1x MOPS buffer for 10 min at 90V (5 V/cm). Then samples and a 
1kb DNA ladder were loaded and electrophoresis was run at 90 V for 4 hours. The RNA-
bands were stained with SYBR® gold, diluted 1:1000 in 1x MOPS buffer, for 60min.  
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  2.2.4 RNA decay assay 
 
To examine potential changes in mRNA stability between treated and control cells, RNA 
decay assays were performed. By incubating living cells with a transcription inhibitor and 
harvesting them at certain time points after addition, mRNA half-lives can be measured.  
RNA synthesis was blocked by Actinomycin D (95% pure, cell culture tested Actinomycin D 
from Sigma, dissolved in DMSO to a stock concentration of 2mg/ml and stored at -20°C). 
Actinomycin D is an antibiotic that inhibits cell proliferation by intercalation of the 
guanosine residues of double-stranded DNA, thus interfering with the binding of DNA-
dependant RNA-polymerase. The compound was added directly into the cell culture 
medium at a concentration of 6µg/ml (5µM). Cells were lysed using TRIzol, first at the time 
when the transcription inhibitor was added (time point 0), then again 3 hours and 6 hours 
later. Total RNA was isolated (see 2.2.3) and reverse-transcribed into cDNA, so that the 
mRNA levels from each of the three samples taken at different time points could be 
assessed by qPCR. Thus the decay rate of β-actin mRNA was compared to those of a set of 
reference genes, after the putative stabilizing factors had been knocked down or 
overexpressed. An untreated sample was always included as a control of successful RNA 
decay.  
 
2.2.5 Protein quantification 
 
Protein isolation with TRIzol® 
 
After the addition of chloroform to the cells suspended in Trizol, proteins were isolated 
from the organic phase according to the manufacturer’s protocol. 
The aqueous phase- which could be further used for RNA isolation- was removed, 300μl 
ethanol were added, mixed by inversion and incubated for 2-3 min at RT to precipitate the 
DNA from the interphase. DNA was pelleted at 2,000g and 4°C for 5 min. The phenol-
ethanol supernatant was transferred into a 2 ml tubes, then 1.5 ml isopropanol were 
added and the mix was incubated at RT for 10 min. After centrifugation at 12,000 g and 4°C 
for 10 min, the protein pellet was washed with 2 ml 0.3M guanidine hydrochloride in 95% 
ethanol for 20 min at RT and centrifuged at 7,600g and 4°C for 5 min. This washing step 
was repeated twice, then the pellet was vortexed in 2 ml ethanol, incubated again for 20 
min and centrifuged as before. The protein pellet was air-dried for approximately 20 min, 
before resuspending it in 1% SDS. To dissolve the protein completely, it was heated at 50°C 
for 10-20min. Protein suspensions were stored at -20°C. To obtain higher concentrations, 
proteins could be subsequently precipitated by use of the TCA-DOC method. 
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Protein Precipitation (TCA-DOC method) 
 
The protein solution was vortexed with 0.02% DOC (deoxycholate) and incubated for 5 min 
on ice. After adding 11% TCA (trichloroacetic acid), the mixture was vortexed and 
incubated for at least 30 min on ice, then centrifuged at 14,000 rpm and 4°C for 20 min. 
The pellet was washed once with 1ml cold acetone, vortexed and centrifuged at 14,000 
rpm and 4°C for 5 min. Again the supernatant was removed and the protein pellet was air-
dried at RT and finally resupended in 2x Laemmli.  
 
Measurement of protein concentration – Bradford method 
 
To determine the protein concentration, a Bradford assay was performed, which is based 
on an absorbance shift in the dye Coomassie from 465 nm to 595 nm, when the Coomassie 
reagent stabilizes its anionic form by the binding of protein.  First the Bradford solution 
(Bio-RAD Protein Assay reagent) was diluted 1:4 in ddH₂O. Dilution series of BSA ranging 
from concentrations of 1-8 µg/ml served as a standard. For sample measurements, a 
certain amount of sample, usually diluted 1:10, was added to 1 ml of the Bradford reagent, 
until its colour would be in the range of the standards. After 5 min incubation at RT, the 
absorption at 595 nm was measured. The concentration of protein in a sample could then 
be calculated using the standards. 
 
Preparation of protein lysates 
 
2x Laemmli was heated to 95°C, of which 250 µl were added to a 6 cm dish (with 750k 
cells). The cells were scraped with a cell scraper (Greiner bio-one) and transferred into an 
Eppendorf tube. The lysate was heated to 95°C for 10 min while shaking at 400 rpm. After 
centrifugation at 14,000 rpm for 10 min at room temperature, the supernatant was 
collected and stored at -20°C. Before using it for an SDS-PAGE, it was reheated to 95°C for 
app. 5min at 400rpm. At 750,000 cells per dish, 35 µl of the lysate (from one dish) – the 
maximum loading volume for a 1.5 mm gel – should contain up to 40 µg protein. 
 
SDS-PAGE 
 
During SDS (Sodium dodecyl sulfate)-polyacrylamide gel electrophoresis, SDS denatures 
and binds proteins, applying negative charges to them. The proteins will then move 
towards an anode through the gel pores, thereby being separated according to their 
molecular weight, the smaller proteins moving faster. 10-50 μg of protein in Laemmli 
buffer were denaturated at 95°C for 5 min and were subsequently loaded on a 1.5 mm 
thick, 10% SDS-PA gel, together with 4 µl of PageRuler™ Prestained Protein Ladder 
(Fermentas). Proteins were separated at 130 V for 90 min.  
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Western Blot 
 
Proteins separated by a SDS-PAGE were blotted onto a nitrocellulose membrane using the 
Bio-Rad tank blotting system. For one gel, 2 sponges, 4 filter papers and a nitrocellulose 
membrane were equilibrated in cold Blotting Buffer. They were assembled into a sandwich, 
gel and membrane being enveloped by 2 filters and a sponge one either side, avoiding air 
bubbles. Importantly, the gel has to be at the same side as the cathode and the membrane 
at the side of the anode, so that the negatively charged proteins will move to the 
membrane.  
While amperage of 250 mA was applied for 90 min, the buffer tank was kept cold on ice 
under constant stirring. To confirm successful transfer of protein, the membrane was then 
stained with Ponceau S. Then the membrane could be cut for the following probing of the 
proteins of interest. To reduce unspecific binding, the membrane was blocked for 30 min at 
RT in Detector™ Block solution (KPL) +NaN₃ while shaking. Incubation with the respective 
primary antibodies, diluted in Detector™Block, was carried out either for 2 h at RT or 
overnight at 4°C, on a shaker. Afterwards the membrane was washed at least twice for 15 
min at RT with 1x TBS Buffer containing 0.1% Tween. Then the blot was incubated with the 
secondary antibody diluted in Detector™ Block for 45 min at RT, shaking in the dark. After 
washing it as previously, it was scanned using the Odyssey® Infrared Imaging System (LI-
COR® Biosciences). Quantifications were performed using the Odyssey® Application 
Software 2.1. 
 
2.2.6 Luciferase Assay (Promega Dual-Luciferase® Reporter 1000 Assay System) 
 
Luciferase assays were employed to assess putative regulatory properties of a DNA 
sequence on the transcription and/or translation of a reporter gene. The sequence of 
interest (for example a 3’-UTR) was cloned into a vector with a luciferase gene, which 
served as reporter. Luciferases are enzymes that catalyze bioluminescent reactions (see 
figure below). By metabolizing certain substrates, they generate a luminescent signal which 
can be measured and correlated with the amount of the reporter present in a sample. 
Usually the Luciferase activity of a co-transfected reporter serves as an internal control that 
represents baseline translation and is necessary for the normalization of the experimental 
reporter activity to eliminate differences due to varying transfection efficiencies or cell 
viability. 
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Fig. 2.2.2 ©Promega (Dual-Luciferase® Reporter 1000 Assay System Manual) 
 
For this purpose the Dual-Luciferase® Reporter System (Promega) was used, in which the 
activity of firefly luciferase (Photinus pyralis) and of Renilla luciferase (Renilla reniformis or 
sea pansy) are measured successively from a single sample. PsiCHECK™-2 (Promega) served 
as an expression vector carrying the genes for both luciferases. The main advantage of this 
system is to avoid triple transfections (of a reporter and a control plasmid together with an 
effector plasmid), thereby making normalization more reliable. The sequences of interest 
(for example a 3’-UTR) were cloned into a multiple cloning site at the 3’ end of the firefly 
luciferase expression cassette of psiCHECK™-2 vectors using the XhoI and NotI restriction 
sites.  
Neurons at 0 DIV were transfected with the reporter constructs and either a silencing- or 
overexpression plasmid at a ratio of 1:4 by nucleoporation and plated into a 24-well-plate 
(HeLa cells were transfected by FuGene lipofection), mostly in triplicates. After either 24 
hours (for overexpression) or 96 hours (for knockdown), the culture medium was removed 
and cells were washed once with pre-warmed PBS. Afterwards they were lysed by 
incubation with 1x Passive Lysis Buffer (150 µl/well; 5x Lysis Buffer diluted in ddH2O) for 30 
min at RT while shaking. 50 µl of the lysate were transferred into a 96-well-plate. Before 
starting the assay in the GloMax® 96 Microplate-Luminometer (Promega), an automatic 
priming sequence was initiated so that both autoinjectors would be filled with the 
respective reagent, LARII or Stop & Glo®.  
The Promega protocol for Dual Luciferase Reactions with Two Injections of the GloMax® 96 
Software was run to measure the luminescence intensities. The injection volume was set to 
50 µl and the delay between injection and measurement was changed to 2 s, whereas the 
rest of the program settings were maintained. First firefly luciferase reporter activity was 
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measured after adding 50 µl of its substrate (Luciferase Assay Reagent II). Afterwards 50 µl 
Stop & Glo® Reagent were injected into the same tube, quenching the previous reaction 
and simultaneously initiating the Renilla luciferase reaction. The injectors were flushed 
with ddH2O and 70% ethanol after every run according to the manufacturer’s 
specifications. 
 For the quantification of reporter activity after measuring of the luminescence, the 
intensity of luminescence from the firefly luciferase was always normalized to the Renilla 
intensity of the same sample. Parallel assays with empty psiCHECK™-2 vectors also served 
as a control. 
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III  Results 
3.1  Investigating a novel siRNA delivery method for the downregulation of 
Staufen2 and ZBP1 in primary neurons  
3.1.1 Establishing successful transfection of primary neurons  
A frequently applied method for the transient downregulation of specific proteins in primary 
cells is the use of short hairpin vectors. They contain palindromes of 19 nucleotides 
complementary to the sequence to be silenced. The resulting transcript should fold into a 
hairpin precursor and is supposed to be processed by the endogenous microRNA machinery 
into functional siRNA. Albeit all obvious merits, there are certain limitations to this method. 
First, not all proteins are equally accessible to it; some are difficult to downregulate to a 
measurable extent. Another restriction is imposed by the transfection of these vectors into 
neurons, because of all transfection methods that had so far been used in our lab, only 
nucleofection before plating yielded numbers of transfected cells high enough for 
subsequent analysis by biochemical or molecular methods. Therefore, transfection of more 
developed neurons with sufficient yields had not been possible. As for one of the proteins I 
wanted to investigate, namely ZBP1, all previous attempts to downregulate it with short 
hairpin vectors had been unsuccessful, a novel method was tested, Accell® siRNA provided 
by Dharmacon®. These modified, double-stranded oligonucleotides have the ability to enter 
the cytoplasm of cells without any additional transfection reagent, since they are coupled to 
a cholesterol moiety via an alcohol-amine linker region (for an example of the Accell® oligo 
structure see Fig. 3.1c). Thus this procedure would yield several advantages: first, it is less 
harmful than nucleofection, which always results in a certain number of destroyed cells; 
secondly, silencing can be induced in cells of any age.  
First the viability of hippocampal neurons was tested, after their neuronal medium 
(NMEM+B27) was replaced by Accell® delivery medium (having an unrevealed formulation) 
at 3 DIV (days in vitro) either as is or supplemented with B27, a factor necessary for neuronal 
growth. After an incubation period of 48 hours, visual assessment of these cells showed 
severely reduced viability in Accell® delivery medium both with and without the supplement. 
Therefore, the possibility of transfection with Accell® siRNA without substitution of NMEM 
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was assessed using a FAM labeled, control Accell® siRNA, emitting at 518 nm due to the 
attached fluorophore. This control siRNA is not supposed to target any RNA, which was 
confirmed by BLAST search. The standard delivery protocol supplied by the company (Fig. 
3.1a) was slightly modified to fit the needs of our primary cultures. Subsequently, the oligos 
were only added to cultures after 3 DIV, so that cells could adhere properly. Also, to 
minimize waste of expensive reagents, only half of the recommended amount of oligos was 
used (0.5 µM), since the viability of neurons depends on a relatively large volume of media, 
and they cannot be grown too densely.  Whenever a reduced volume of neuronal medium 
was used, it was partly exchanged for fresh medium after 48 hours, which is the 
recommended minimum duration for siRNA uptake according to the company’s instructions. 
Transfection was visualized by fluorescence microscopy 72 hours after the addition of siRNA 
(Fig. 3.1b). To our advantage, transfection efficiencies did not seem to be influenced 
significantly by a lack of Accell® delivery medium, while neuronal survival was much better in 
NMEM (Fig. 3.2a). Alternatively, cells were grown in neuronal medium combined with either 
50% or 25% of Accell® delivery medium, yet transfection efficiency or cell viability did not 
appear visibly changed in either case. Therefore, in all following experiments NMEM+B27 
was used instead.  
 
To determine the transfection rate, 3 days after treatment with siRNA 379 cells were 
counted, of which 204 (53.8%) were fluorescent; however, this is most likely an 
underestimation of the transfection rate with unlabeled oligos due to very stringent 
counting criteria and interference of the fluorophore with transfection.  
As a proof for successful downregulation, quantitative real-time PCR was performed. 
Hippocampal neurons (2 culture dishes of 0.5 million cells per condition) were grown 3 DIV 
before the siRNA was added to the neuronal medium. Oligonucleotides targeting the 
housekeeping gene GAPDH were used as a positive control for efficient knockdown. 48 
hours later the medium was exchanged, cells were lysed 72 hours after transfection and 
total RNA and protein were extracted with Trizol. The isolated RNA was reverse transcribed 
into cDNA and used for quantitative real-time PCR using GAPDH primers and the MiQ BioRad 
SYBR-Green supermix. Results were evaluated using the ∆∆Ct -method (Schmittgen & Livak, 
2008). Thereby, GAPDH mRNA levels in hippocampal neurons could be efficiently reduced by 
addition of Accell® siRNA. The average reduction of GAPDH mRNA was 77% in treated 
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compared to untreated cells (Fig. 3.2b). Actual numbers varied considerably between 
individual experiments, probably due to differences in the numbers of transfected cells, as 
well as slight variances in reference gene expression, in this case Tubulin.  
To obtain a condition more comparable to siRNA-treated cells than simply untransfected 
neurons, cells were treated with a non-targeting Accell® siRNA, which ideally should not 
cause any changes in mRNA levels. Stau2 mRNA levels of untransfected neurons and such 
treated with NT (non-targeting) siRNA were compared by qPCR. Notwithstanding a 
considerable variation between experiments, on average changes between transfected and 
untransfected cells were insignificant (Fig. 3.2c). Therefore, non-targeting siRNA was further 
used as a negative control.  
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Figure 3.1 - Accell® siRNA  
Schematic description of (A) the standard protocol (© www.dharmacon.com) and (B) the modified delivery 
protocol of Accell siRNA. Following the modified protocol, 0.5 µM Accell siRNA were added to the neurons in 
NMEM+B27 medium 3 days after plating, the medium could be exchanged 48 hours later, and cells were used 
for assays after 72 hours. (C) Exemplified structure of an Accell oligo. 
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A     
 
B                   C 
  
Figure 3.2 – Assessing the efficiency of Accell® siRNAs in primary neurons 
(A) Testing the transfection efficiency of Accell® siRNA in hippocampal neurons by transfection with FAM-
labeled oligos. Pictures were taken with a Leica MZ 16F. 
(B-C) Evaluation of the effects of Accell® siRNA in neurons by qPCR. (B) Hippocampal neurons were treated with 
siRNA targeting GAPDH, as a positive control for efficient knockdown. A reduction of GAPDH mRNA levels was 
confirmed by qPCR in 4 individual experiments. (C) A non-targeting siRNA (NT), which is not supposed to induce 
any effect, was also tested and did not lead to significant changes of Stau2 mRNA levels compared to 
untransfected (UT) neurons.   
GAPDH mRNA Stau2 mRNA 
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3.1.2 Testing 4 different siRNAs for both Staufen2 and ZBP1 
After modifying the protocol so that the Accell® siRNA method was effective in primary 
neurons, sets of 4 different siRNAs were examined targeting either Stau2 or ZBP1. Their 
sequences, as well as the sequence of the non-targeting siRNA are provided in Table 3a. To 
examine which of those oligonucleotides would decrease Stau2 or ZBP1 mRNA levels most 
efficiently, neurons were transfected with either one of the four siRNAs (labeled #13 to 16 
by the company) targeting either Stau2 or ZBP1. Subsequently, amounts of Stau2 and ZBP1 
mRNA were quantified by qPCR, and transfected cells were compared with untreated cells. 
Tubulin and GAPDH were used as reference genes, for which real-time primer sequences – 
as well as all other primers that were used – are given in chapter 2.1.7.  Transfection with 
any of the 4 siRNAs against Stau2 resulted in significant downregulation of Stau2 mRNA (Fig. 
3.3b, left chart), whereas siRNA #14 showed to be most effective in two individual 
experiments, reducing the Stau2 mRNA in treated cells to 16% of the level in untreated cells. 
A repetition of the experiment with cells treated with siRNAs against ZBP1 numbered #13-16 
gave differing results. This time, not every siRNA worked equally well, with siZBP1 #13 giving 
the strongest effect, leading to a downregulation of ZBP1 mRNA to an average of 27% 
compared to untransfected cells (Fig. 3.3b, right diagram). In accordance with these results, 
the most effective siRNAs were used for further experiments, namely the siRNA targeting 
Stau2 #14 and the siRNA #13 against ZBP1. Their sequences are highlighted in red in Table 
3a. 
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A 
Accell oligos Target sequences 
siRNA Staufen2 
(Set of 4 siRNAs) 
siSTAU2 #13 CUUUUAUGUUCAGUUGACU 
siSTAU2 #14 CCGUCAGUUUUGAGGUUAU 
siSTAU2 #15 GCCAUAGGUUUAAAAGGAA 
siSTAU2 #16 CGAGUAUGGUCAAGGAAUG 
siRNA ZBP1 
(Set of 4 siRNAs) 
siZBP1 #13 CUCCAAAGUUCGAAUGGUU 
siZBP1 #14 UUGUUAAGAUCAUCGGACA 
siZBP1 #15 UUGCGGAGCACAAGAUCUC 
siZBP1 #16 CCUGAAGGUUUCCUACAUA 
negative control Non-targeting siRNA UAAGGCUAUGAAGAGAUAC 
positive control GAPDH siRNA  
transfection control FAM-labeled non-targeting siRNA UAAGGCUAUGAAGAGAUAC 
 
B  
 
Figure 3.3 - Testing sets of 4 different Accell® siRNAs per target 
(A) Table of Accell oligos directed against Stau2 and ZBP1 and their target sequences. 4 different siRNAs were 
tested for each gene. Red sequences indicate the oligos that were used for further experiments. The sequence 
of the non-targeting siRNA is also given, which was used as negative control or transfection control, when 
coupled to a fluorescent molecule. The sequence of the siRNA targeting GAPDH was not revealed by the 
company. 
(B) Evaluation of the knockdown efficiencies of each oligo by qPCR. The reduction of mRNA by four different 
siRNAs targeting Stau2 and ZBP1, respectively, was compared. The oligos in a set were labeled by the company 
with the numbers 13 to 16. Two individual experiments were performed, error bars indicate standard 
deviation. The quantitative ΔΔ-Ct method was employed, and measured RNA levels of transfected cells were 
set in relation to those of untransfected (UT) cells. 
  
13 14 15 16 UT 
Stau2 mRNA 35% 16% 24% 22% 100% 
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13 14 15 16 UT 
ZBP1 mRNA 27% 49% 59% 71% 100% 
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3.2 A comparison between pSuperior plasmids and Accell® siRNA 
 
3.2.1  Assessing the downregulation of mRNA levels by quantitative real-time 
PCR 
Once a protocol for Stau2 knockdown with Accell® siRNAs was established, the actual effects 
of this knockdown, in particular on β-actin mRNA, were examined. However, preliminary 
experiments concerning putative changes of β-actin mRNA and protein as well as the overall 
actin cytoskeleton, which will all be described consecutively, showed certain diversions from 
previous experiences in the lab. As for all preceding experiments short hairpin vectors had 
been used for Stau2 knockdown, the question arose, whether different methods of 
downregulation could be responsible for the conflicting results, possibly due to unwanted 
side effects. Therefore, a closer investigation of the discrepancy between the effects of 
Accell® siRNA and the pSuperior system – a type of short hairpin vector that had been used 
previously – seemed appropriate.  
To exclude that differing target sequences were the reason for different outcomes, 
irrespective of the method used, pSuperior plasmids were cloned containing the exact 
sequences of the Accell® siRNAs against Stau2 (#14) and ZBP1 (# 13), respectively. For the 
cloning of these sequences into pSUPERIOR.neo+gfp vectors (OligoEngine), forward and 
reverse primers (ordered from Sigma-Aldrich) containing the 19-nt target sequence were 
annealed and ligated with the linearized pSuperior vector following manufacturer’s 
instructions (for a more detailed description see 2.2.1.1). These newly constructed plasmids 
subsequently will be called shStau2 and shZBP1, to discern them from the Accell® siRNAs, 
from now on termed siStau2 and siZBP1. Neurons were transfected with these vectors as 
well as with a previously used pSuperior plasmid targeting Stau2 (siStau2-2, Goetze et al., 
2006) using Amaxa® nucleofection. After 3 to 4 DIV the cells were lysed and assayed by 
qPCR. In parallel, neurons treated with siRNA targeting Stau2 at 3DIV, were also tested after 
3 to 4 days.  As a negative control, cells were transfected with either the pSuperior vector 
containing a mismatch in its target sequence (misStau2), with empty pSuperior or non-
targeting siRNA. The effects of these different treatments on Stau2 mRNA levels determined 
by qPCR are shown in Fig. 3.4a. 7 individual experiments were performed with the siRNA and 
3 with each pSuperior plasmid, using partly hippocampal and partly cortical neuron cultures. 
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Which culture type was used and for how long cells were incubated after transfection – 
either 3 or 4 days – had no apparent influence on the outcome of these experiments. In all 
cases certain variations between experiments occurred, most likely due to differences in the 
success of transfection or slight variations of individual cell cultures. The average quantity of 
Stau2 mRNA in treated neurons was compared to untreated neurons (Fig. 3.4a, light blue 
bars), or neurons transfected with a mismatch plasmid or a non-targeting siRNA (blue bars). 
In the case of the plasmid siStau2-2, results were compared to the mismatch plasmid or to 
the empty pSuperior (purple bar). The amount of Stau2 mRNA changed only slightly, ranging 
from a reduction to 33% by Accell® oligos to 45% by the shStau2 plasmid with the same 
sequence, in comparison to the control. These differences may be caused by varying 
transfection efficacies. However, the difference between cells transfected with the control 
plasmids/siRNA (in relation to untransfected cells, green bars) and the knockdown 
plasmids/siRNA are significant (p-value < 0.05), thereby proving that both systems lead to 
efficient Stau2 downregulation. The significance was determined by student’s t-test.  
Similar experiments were performed using the plasmid and siRNA targeting ZBP1. Neurons 
treated with siZBP1 showed a decrease of ZBP1 mRNA down to 43% of the non-targeting 
siRNA treated cells (Fig. 3.4b, red bar).  An experiment using a pSuperior plasmid with the 
same target sequence, however, did not lead to a significant knockdown of ZBP1, which 
corresponds to previous failed attempts to downregulate ZBP1 with the use of short hairpin 
vectors. While the outcome achieved with siZBP1 seemed rather promising according to the 
qPCR results, reaching stable reductions of protein levels proved to be more challenging. 
 
3.2.2 Comparing the effects of pSuperior and Accell® siRNA on the protein level  
To determine the effects of these two different methods of downregulation on the protein 
levels of Stau2 and ZBP1, protein samples were separated on denaturing gels and probed by 
Western Blotting. Either total protein was extracted using Trizol® – which has the advantage 
that the RNA can be used for qPCR in parallel, but results in relatively low yields – or whole 
cell lysates were loaded on SDS gels. Fig. 3.4c shows a representative blot, for which neurons 
(3 DIV) were treated with oligonucleotides targeting Stau2 or ZBP1, or GAPDH as a positive 
control. Non-targeting siRNA (NT) served once more as negative control. The left half of the 
membrane was stained with antibodies against Stau2 (anti-Stau2 rabbit serum), while the 
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right half was stained with ZBP1 antibodies (rabbit serum). The membrane was then 
decorated with antibodies against GAPDH, β-actin and Tubulin (all mouse monoclonal 
antibodies). Secondary antibodies from LI-COR Biosciences, donkey anti-rabbit 488 (green 
fluorescence) or anti-mouse Cy3 (red) were used. After scanning the membrane using the 
Odyssey Infrared Imaging System®, the intensities of relevant bands were measured and 
normalized to the intensities of the Tubulin band of the same lane (at 55 kDa), Tubulin being 
used as a loading control. Tubulin antibodies were not isoform-specific. The intensities of 
GAPDH bands (found at 36kDa) are reduced in the protein extract from neurons treated with 
siRNA targeting GAPDH, whereas they are not significantly decreased in any other sample. 
Against our expectations after real-time PCR results, the ZBP1 band (68 kDa) does not differ 
between the siZBP1 treated and the control samples. However, downregulation of Stau2 by 
Accell® siRNA on the protein level was successful. The quantification of the 3 major isoforms 
of Stau2 at the size of 52kDa, 59kDa and 62kDa, is depicted in Fig. 3.4d. The intensities of the 
different Stau2 bands were normalized to Tubulin and set in relation to non-targeting siRNA 
transfected cells: the respective band intensities from the control were therefore set to 
100%. The neurons treated with siStau2 (blue bars) contained significantly less of all Stau2 
isoforms, whereas siGAPDH treated cells (light blue bars) showed only minor variations. Yet 
the isoforms are not present at equal amounts after down-regulation. The reduction varies 
considerably, and the strongest decrease to 29% of the control is seen in the 59 kDa isoform, 
while the 52 kDa isoform is least affected, with 55% of the control remaining.  
Corresponding experiments with neurons transfected with sh-plasmids yielded comparable 
results, as can be seen in Fig. 3.4e. The amount of Stau2 protein was decreased by 
nucleofection at DIV 0 with the pSuperior plasmids siStau2-2 and shStau2 in comparison to 
the controls, the mismatch plasmid (Stau2mis) and empty pSuperior. Tubulin was again used 
as a loading control. Downregulation of ZBP1 was also tested once more with the use of the 
pSuperior plasmid shZBP1, as well as with a different sh-plasmid (generously provided by 
Stefan Hüttelmaier) based on the psiSTRIKE™ U6 Hairpin Cloning System (Promega), named 
shIMP1 (after the human homologue of ZBP1). The controls used were the empty pSuperior 
vector and a mismatch plasmid to shIMP1. However, no decreased intensity of the ZBP1 
bands could be observed in either case (Fig. 3.4e, right side). 
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Figure 3.4 – Knockdown efficiency of short hairpin vectors (Amaxa® nucleofection) compared to 
Accell® siRNA 
(A) Comparison of Stau2 mRNA levels by qPCR. Neurons were transfected either with Accell® siRNA targeting 
Stau2 or with one of two different shStau2 pSuperior plasmids by Amaxa® nucleofection: siStau2-2 (middle), a 
plasmid that had been previously established in the lab, and a new pSuperior plasmid (right), with a matching 
target sequence to the Accell® siRNA. 7 individual experiments were performed with the siRNA (n=7), and 3 
with each pSuperior plasmid (n=3); results are given in percentage of Stau2 mRNA from transfected cells, 
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compared to either untransfected cells or to neurons transfected with control plasmids (containing a 
mismatch).  Green bars depict RNA levels in mismatch-transfected compared to untransfected cells. Asterisks 
indicate significance by student’s t-test [p >0.05- not significant; p <0.05- *; p<0.01- **;p<0,001- ***]. 
(B) ZBP1 mRNA levels determined by qPCR. Neurons were transfected with shZBP1 pSuperior plasmids (n=1) 
containing the same target sequence as the respective Accell® oligo (n=2). 
(C-E) Assessing downregulation of Stau2 and ZBP1 at the protein level by Western Blot. (C) Accell siRNA 
targeting Stau2 and ZBP1, as well as GAPDH, as a positive control for down-regulation: A representative 
Western blot is shown (anti-Stau2 rabbit H7 1:500, 3 bands of 62, 59 and 52 kDa; anti-ZBP1 rabbit serum 1:600, 
68 kDa; anti-GAPDH mouse mAb 1:1500, 37kDa), Tubulin (mouse anti-Tubulin 1:5,000, 55kDa) was used as 
loading control. See quantification of the intensities of the 3 Stau2 bands (indicated by arrows) below (D).  
Intensities of cells transfected with siNon-targeting are set to 100%, and siStau2 transfected cells (blue bars) 
are compared to siGAPDH transfected cells (light blue). (E) Nucleofection with plasmids for the down-
regulation of Stau2 (siStau2-2, Stau2 mismatch, empty pSuperior, and shStau2) or ZBP1 (the pSuperior based 
construct shZBP1, and the psiSTRIKE vectors shIMP1 and shIMP1 mismatch). 
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3.3 Consequences of decreased amounts of cellular Staufen2 on β-actin  
 
3.3.1  Effects of Staufen2 knockdown on β-actin mRNA  
 
The next steps concerned the investigation of the influence of trans-acting factors on β-actin 
in young neurons. This actin isoform is enriched in dynamic structures like growth cones or 
filopodia, where cytoskeletal rearrangements take place Stau2 has been shown to affect 
both β-actin localization and the morphogenesis of dendritic spines in mature neurons 
(Goetze et al., 2006). During the development of young neurons, a role of Stau2 in the 
regulation of β-actin levels and axonal outgrowth has been suggested (Y. Xie, P. Macchi and 
M. Kiebler, unpublished results). Another protein involved in the transport of β-actin mRNA 
is ZBP1, which binds to a sequence known as “zipcode” in the β-actin 3’-UTR (Ross et al., 
1997). As a result of the insufficient knockdown of ZBP1, however, I decided to concentrate 
on unraveling the role of Stau2 in this process by downregulating Stau2 in primary neurons.  
First, β-actin mRNA levels were analyzed by qPCR. Initially, the chosen reference genes 
caused problems, since the housekeeping genes GAPDH and Tubulin, which are supposed to 
remain constant throughout treatments, were also affected by Stau2 knockdown. Thus, a set 
of several typical reference genes was used from there on for internal cross-normalization 
(Weidensdorfer et al., 2009) to balance out the deviations of individual genes, including 
cyclophilin A, vinculin, 18S ribosomal RNA, γ-actin and septin7. New real-time primers for 
these reference genes were designed by A. Konecna or by adapting sequences from S. 
Hüttelmaier (pers. communication), and all were confirmed by standard curve assays. Only 
primers working in a linear range and with efficiency close to 100% were used. Amongst the 
aforementioned reference genes, however, 18S rRNA was least suitable. The ribosomal RNA 
is extremely abundant. Therefore, cDNA samples always had to be diluted more than 
samples used with other real-time PCR primers, usually 1:100 instead of 1:10. Septin7, on 
the other hand, which was suggested to be especially unaffected by Stau2 (M. Mikl, diploma 
thesis), is present at very low cellular levels and thus was also not an ideal reference for the 
highly abundant β-actin.   
 
For Stau2 knockdown, hippocampal or cortical neuron cultures were treated with Accell® 
siRNA at 3 DIV and analyzed after 72 hours of incubation in several individual experiments. 
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Fig. 3.5a shows a quantification of β-actin mRNA from these cultures in relation to siNT 
treated (blue bar) or untransfected neurons (green bar). In both cases, the β-actin level 
appeared to be unaffected by a reduction of Stau2, which was also confirmed during each 
qPCR experiment. The transfection with pSuperior plasmids yielded quite different results 
(see Fig. 3.5b), with clear reductions of β-actin mRNA quantities compared to cells 
transfected with the corresponding mismatch plasmid or empty pSuperior (set to 100%, 
indicated by the red line). During one experiment (data not shown), where transfection had 
apparently been insufficient and Stau2 mRNA was still present at 76% of the control, 
practically no reduction of β-actin mRNA was observed (96% of the control), thereby 
representing another indication for a direct relationship between Stau2 and β-actin levels.  
A slightly stronger effect than with shStau2 was observed with the plasmid siStau2-2, which 
reduced the β-actin mRNA level by almost 40%. However, as the plasmid shStau2, which 
shares its target sequence with the Accell® oligo siStau2, also leads to a β-actin 
downregulation, the disparity in effect does not seem to be strictly sequence specific. In the 
case of nucleofection with plasmids, neurons were treated before plating and analyzed after 
4 DIV. To examine whether Stau2 downregulation at an earlier stage would cause β-actin 
changes, experiments with Accell® siRNA were also performed at 0 DIV and analyzed after 4 
days, while otherwise the oligonucleotides had not been added before cell adherence. Of 
two individual experiments, one had to be excluded due to very atypical qPCR results, the 
other one is shown in Fig. 3.5a on the right. While the Stau2 levels were reduced in the usual 
range upon siRNA treatment, a clear decrease of the β-actin mRNA level to approximately 
half of the level compared to untransfected cells could be observed. NT siRNA had no 
significant effect, as would be expected.  
 
  
3.3.2 Evaluating β-actin protein levels after up- or downregulation of trans-
acting factors 
 
To validate the effect seen at the mRNA level, the cellular protein contents were analyzed 
using the Western Blot technique. Blots were stained with antibodies against β-actin and 
Tubulin as loading control (both are mouse monoclonal Antibodies from Sigma, their 
specificity had been previously tested in the lab). A representative blot from cortical neurons 
transfected at 3 DIV with Accell® siRNA targeting Stau2, ZBP1 and GAPDH, as well as with 
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non-targeting siRNA, is shown in Fig. 3.6a. Tubulin (55 kDa) and β-actin bands (42 kDa) are 
presented together with a prestained protein marker. The intensities of β-actin bands were 
measured and normalized to Tubulin intensities; the values below the bands represent the 
percentage of β-actin levels relative to the respective control, which is indicated by green 
numbers. Analogous to the mRNA quantities determined by qPCR, no obvious changes of β-
actin on the protein level could be observed. The diagram on the right visualizes these 
results. As before, these experiments were repeated using the plasmids shStau2 and siStau2-
2 for the downregulation of Stau2 and the empty vector as a control. Cortical neurons were 
analyzed 4 days after nucleofection; an example of the resulting Western blots is depicted in 
Fig. 3.6. To test whether opposing effects of overexpression and downregulation of Stau2 on 
the expression of β-actin would be detectable, neurons were transfected simultaneously 
with an overexpression construct of Stau2 fused to EGFP, as well as with the empty pEGFP 
plasmid, and analyzed after 1 DIV. The successful overexpression is visualized by Stau2 
antibody staining; pEGFP-Stau2 is detected at approximately 95kDa (see Fig. 3.6b, left). Yet, 
neither overexpression nor downregulation of Stau2 caused significant changes in the 
intensities of β-actin bands.  
 
Additionally, a putative effect of ZBP1 was also examined by transfection with the plasmids 
shZBP1 and shIMP1. As a significant and reproducible decrease of ZBP1 protein levels in 
primary neurons using these constructs was not possible (Fig. 3.6c), it is not surprising that – 
in spite of certain variations – stable changes in β-actin intensities did not occur in relation to 
transfections with empty pSuperior or ZBP1 mismatch (see Fig. 3.6c). Overexpression of 
ZBP1, on the other hand, worked well, the 95kDa band of pEGFP-ZBP1 being clearly visible 
by staining with anti-ZBP1 antibodies, yet again without any significant effect on the β-actin 
staining. To ensure that the rabbit serum antibody against ZBP1 was definitely specific, it 
was compared to the mouse monoclonal antibody (gift from S. Hüttelmaier) on a test blot 
with 10µg brain lysate. Though the staining with the mouse antibody was very weak, at least 
the band it stained proved to be identical to the main band stained by the much stronger 
rabbit antibody (Fig. 3.6c, right side).  
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3.5 - Changes in β-actin mRNA levels after Stau2 knockdown  
(A) The amount of β-actin mRNA after knockdown of Stau2 with Accell siRNA was measured by qPCR.  Cultures 
of hippocampal or cortical neurons were usually transfected at day 3 and analyzed after 72 hours (left side; 6 
individual experiments). Once the siRNA was added at day 0 and cells were analyzed after 4 days, which yielded 
differing result (right side). All results stand in relation to either cells transfected with non-targeting siRNA (NT) 
or to untransfected neurons (UT). 
(B) Quantification of β-actin mRNA by qPCR after downregulation of Stau2 with two different pSuperior 
constructs, siStau2-2 (pre-existing plasmid) and shStau2 (plasmid with a target sequence corresponding to the 
Accell® oligo siStau2). ß-actin levels of transfected cells are shown relative to those of cells transfected with 
either a mismatch sh-plasmid or empty pSuperior (which were thus set to 100%, indicated by the red line). 
Cortical neurons were transfected before plating and used for assays after 4 days (2 experiments). 
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3.6 - Changes in β-actin protein levels after Stau2 knockdown 
(A-C) Western Blots to determine changes in β-actin protein levels. Blots were stained with β-actin antibodies 
(mouse, 1:2,500; 42 kDa band) and Tubulin antibodies (mouse, 1:5,000; 55 kDa band).  The intensities of bands 
were quantified using the Odyssey® Application Software. Intensities of β-actin bands were normalized to 
Tubulin; the numbers are given below every band, in percentage of the respective control (the controls are 
therefore set to 100%, green numbers). (A) A representative blot from cortical neurons transfected with Accell 
siRNA (3+3 DIV) targeting Stau2 and ZBP1. A graph (right side) represents the intensities of β-actin bands 
normalized to Tubulin and compared to the siNT transfected cells. siGAPDH and siNon-targeting were used as 
controls. (B) Cortical neurons were nucleofected with pEGFP-Stau2 and analyzed after 1DIV or alternatively, 
with one of two pSuperior plasmids to knockdown Stau2 (shStau2 and siStau2-2) and analyzed after 4 days. 
Transfection with the respective empty vectors served as a control. Stau2 antibodies (rabbit H4, 1:500) 
visualize overexpression of Stau2 (pEGFP-Stau2 band at 95kDa). (C) A blot from cortical neurons transfected 
with pEGFP-ZBP1 and lysed after 1 DIV, the expression of the construct was confirmed by antibodies against 
ZBP1 (rabbit, 1:600; pEGFP-ZBP1 band at 95kDa). Another blot shows transfection with ZBP1 knockdown 
plasmids (shZBP1, a pSuperior vector, and shIMP1, a psiSTRIKE vector), and with empty pSuperior or a 
mismatch vector (of shIMP1). On the right: a test blot with 10 µg brain lysate for two different ZBP1-antibodies 
(anti-ZBP1 rabbit serum, 1:600 and anti-ZBP1 mouse mAb, 1:250). 
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3.3.3 Analysis of the effects of Staufen2 downregulation on the actin 
cytoskeleton  
To test whether an overall effect on the actin cytoskeleton would occur after the 
downregulation of Stau2 (which was suggested by previous work in the Kiebler lab), 
transfected cells were fixed and stained with phalloidin coupled to Alexa fluorophore 
(Invitrogen). Phalloidin is a toxin, derived from the death cap Amanita phalloides, which 
binds specifically to filamentous actin (Löw & Wieland, 1974) and, by stabilizing the junctions 
between actin subunits, inhibits the depolymerization of F-actin (Barden et al., 1987).  
Therefore, coverslips with hippocampal neurons (3 DIV) were either treated with Accell® 
siRNA or transfected by Calcium-Phosphate precipitation (Goetze et al., 2004) Usually after 3 
days, neurons were fixed using PFA and incubated with phalloidin or with antibodies against 
Stau2 or ZBP1 to check for successful down-regulation in treated cells. Additionally, nuclear 
staining with DAPI was performed, and phase contrast pictures were taken to monitor the 
state of the cells. A reduction of signal detected by Stau2 antibodies in siStau2-treated 
neurons is demonstrated in Fig. 3.7a. There was no significant difference in the amount of 
Stau2 between untreated and control cells. Yet, the knockdown of Stau2 did not have any 
obvious effects on the actin staining, neither in cell bodies nor growth cones. The latter 
ones, however, were not examined individually, while the average intensities from the cell 
bodies of a few randomly chosen neurons were measured using the Metamorph software. A 
comparison of the intensities of phalloidin staining from neurons treated with siRNA 
targeting Stau2, ZBP1 or both (in which case equal amounts of each siRNA were used as in 
single transfections), relative to the control revealed no significant differences of F-actin 
levels. Subtle cytoskeletal changes might still have occurred, but their detection would take 
further intensive investigation and the assessment of larger cell numbers or local structures, 
such as protrusions or growth cones. 
Correspondingly, these experiments were also performed in cells transfected at 0 DIV, yet 
the resulting cells looked too damaged for any further evaluation. Mature neurons (up to 18 
DIV) were also transfected. Phalloidin levels in older neurons were similar in treated and 
untreated cells, yet the assessment of individual cells was complicated by an increased 
presence of glia cells, which contain large amounts of actin and are therefore stained very 
brightly by phalloidin (for an example, see Fig. 3.7c). Staining hippocampal neurons 
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transfected with the plasmids siStau2-2 or mismatchStau2 showed that GFP expressing cells 
(marked by arrows) contained in some cases lower actin levels (Fig. 3.7e, middle images), 
while very often no significant changes were seen (top images) relative to the control. As 
these nucleofected cells did not appear to be in ideal condition, any observed changes might 
not necessarily be physiological.  
Since the knockdown of ZBP1 did not work well using siRNA or pSuperior, it is not surprising 
that actin levels were unaffected. Transfections with shIMP1, the aforementioned psiSTRIKE-
plasmid targeting ZBP1, were also tested. Although immunostaining with ZBP1 antibodies 
(mouse anti-ZBP1) was reduced in most transfected cells, they appeared also to be more 
damaged then their untransfected neighbors, thus successful knockdown with this plasmid 
in primary neurons could not yet be proved (data not shown). 
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3.7 – The actin cytoskeleton after Stau2 downregulation 
3-day-old hippocampal rat neurons were treated with siRNA or transfected with plasmids by Calcium-
Phosphate precipitation. After 3 to 4 days, cells were fixed with PFA and stained with the respective antibodies 
or chemicals. (A) Cells that were either untreated (UT), treated with Non-targeting siRNA (siNT) or with siStau2 
were incubated with rabbit anti-Stau2 (1:300, for 2 hours at RT) followed by secondary antibodies (donkey anti-
rabbit Cy3, 1:2,000).  Fluorescent images are depicted in reversed colors. (B) Fluorescent and phase contrast 
images of siRNA- treated or untreated hippocampal neurons (6DIV) after staining with phalloidin (1:500). (C) 
Example of phalloidin staining (red) of glial cells, combined with Stau2 immunostaining (green) and DAPI (blue). 
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(D) Diagram representing mean average intensities (arbitrary units) of phalloidin, measured (using Metamorph) 
from 10 random cell bodies after treatment with siStau2, siZBP1 or both, or with siNT. (E) Hippocampal 
neurons (7DIV) transfected with siStau2-2 (top and middle) or mismatchStau2 (bottom). Transfected cells 
expressing GFP are indicated by orange arrows. Images on the right show the phalloidin staining of these cells. 
 
 
 
3.4 The influence of Staufen2 on the stability of β-actin mRNA  
 
As, at least in some cases, a certain decrease of β-actin mRNA could be seen after 
downregulation of Stau2. Therefore, the question arose, whether this effect would be 
caused by a stabilizing influence of Stau2 on the β-actin message. To assess the stability of 
mRNA, RNA decay assays were performed – a schematic overview on this assay’s principle is 
given in Fig. 3.8a. In this example, Accell oligonucleotides were added at 3 DIV and neurons 
were analyzed 3 days later. When overexpression contructs were used, the assay was 
essentially done in the same way, except that cells were transfected at 0 DIV and analyzed 
24 hours later. The procedure was based on the inhibition of RNA synthesis by adding 5µM 
of Actinomycin D (95%, dissolved in DMSO, Sigma-Aldrich). This toxic compound is an 
antibiotic derived from Streptomyces species, which blocks DNA-primed RNA synthesis by 
forming stable complexes with double-stranded DNA. At the same time as Actinomycin D 
was added (time point 0), total RNA was isolated using Trizol®, and again after 3 hours and 6 
hours. Successively, the β-actin mRNA content of these 3 samples was quantified by qPCR. 
Thus, the degree of mRNA degradation during 6 hours can be monitored and differences 
between treated and untreated or control samples can be compared.  
In any experiment where RNA is quantified, the intactness of the isolated RNA is critical, and 
an RNase-free handling of samples has to be ensured. As a confirmation of the quality of 
RNA samples used for cDNA synthesis and ultimately real-time PCR, a set of 13 randomly 
chosen RNA samples, which were used for these experiments, was tested by RNA gel 
electrophoresis. After running 1 µg of each sample on a 1.5% agarose gel and staining with 
SYBR® gold, two bands became clearly visible (Fig. 3.8b). A DNA marker (M) was used as an 
indicator and RNA extracted from brain lysate (lane 14) was used as a positive control. The 
presence of distinct 28S and 18S rRNA bands at a ratio of approximately a 2:1, as well as the 
absence of smear proved that none of the tested samples showed signs of degradation.  
Fig. 3.9a shows the decay curve of β-actin mRNA after Stau2 knockdown by siRNA in cortical 
neurons. All β-actin amounts were quantified in relation to a set of several reference genes, 
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and the relative β-actin mRNA quantity at the beginning of the decay curve was set to 100%. 
Values from samples treated with siStau2 were compared to those from cells treated with 
non-targeting siRNA and showed a significant decrease after 6 hours, of almost 40% (p <0.05 
by student’s t-test, indicated by an asterisk). A slight effect in the opposite direction was 
observed when neurons had been transfected with pEGFP-Stau2 (Fig. 3.9b). Neurons 
overexpressing Stau2 showed a moderate 1.24-fold increase of β-actin mRNA after inhibiting 
transcription for 6 hours compared to cells transfected with pEGFP, and a 1.78-fold increase 
compared to untransfected neurons (p <0.05). Thus, it seems that pEGFP alone causes minor 
alterations, which does, however, not exclude a small effect of the overexpression of Stau2 
itself on β-actin stability.   
The importance of using several different reference genes for the quantification by qPCR 
using the ∆∆Ct -method has been mentioned before and weighs even more as soon as 
varying decay kinetics of reference genes come into play. The graph in Fig. 3.9c shows an 
example of the variations of β-actin mRNA levels relative to each of four selected reference 
genes - Tubulin, Vinculin, GAPDH and Peptidylprolyl Isomerase A (Cyclophilin A) - in 
untransfected cortical neurons at 1 DIV. Only when the quantities of several genes are 
averaged (black line) during cross-normalization can the differences between the decay of β-
actin and of the reference genes be considered insignificant. 
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3.8 – RNA decay assay  
(A) Schematic depiction of the RNA decay assay method. 3 days after transfection, the RNA synthesis was 
inhibited by addition of Actinomycin D, and then total RNA was isolated at time points 0, 3 and 6 hours. RNA 
levels were then determined by qPCR. 
(B) Verifying the quality of several random RNA samples from various experiments by RNA gel electrophoresis 
(on a 1.5% agarose gel, stained with SYBR® gold). Intact RNA was defined by two prominent bands, the 28S 
rRNA and the 18S rRNA, while degraded RNA would show as a smear. M= 1Kb DNA ladder; lanes 1-13= various 
RNA samples; lane 14= RNA extract from brain lysate (positive control) 
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3. 9 - Decay kinetics of β-actin mRNA  
Graphs show β-actin mRNA levels from samples collected at different time points after RNA synthesis inhibition 
were analyzed using qPCR. The relative amount of β-actin at the start of the decay experiment (t=0h) was 
arbitrarily set to 100%. Error bars indicate the standard deviation of 3 individual experiments. Assays were 
performed after (A) Stau2 knockdown by siRNA in cortical neurons (3+3 DIV), using Non-targeting siRNA as 
control or (B) Stau2 overexpression by transfection of cortical neurons with Stau2-pEGFP (0+1 DIV), using 
empty pEGFP as control. In the latter case, β-actin levels of transfected cells were set into relation with those of 
untransfected cells (purple dots) and of cells transfected with pEGFP alone (green dots). (C) Graph showing the 
differing decay kinetics of four selected reference genes used for quantification by qPCR, namely Tubulin, 
GAPDH, Vinculin (VCL) and Peptidylprolyl isomerase A (cyclophilin A) – as well as their average (black line). All 
relative β-actin levels were set to 1 at t=0. The RNA from 1 day-old untransfected cortical neurons was used.  
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3.5 A comparison of Staufen2 and ZBP1 as regulators of translation 
While mRNA stability seemed to be affected by Stau2, it had yet remained unresolved 
whether Stau2 could also act as a translational regulator. ZBP1 on the other hand had 
already been shown to be involved in translation repression by binding to the “zipcode” in 
the β-actin 3’-UTR (Hüttelmaier et al., 2005). As testing the total protein content by Western 
Blot did not lead to significant results, we looked for a more sensitive method to detect 
possible changes of translation activity and started with luciferase assays (these assays were 
performed in cooperation with L. Schoderböck in the lab). Therefore, 3 different parts of the 
human β-actin sequence had previously been cloned by L. Schoderböck into psiCHECK™-2 
(Promega), a plasmid carrying genes for both renilla and firefly luciferase. These sequences 
included either the coding region and the zipcode (1388 bp) or the full length 3’-UTR (607 
bp), or the zipcode by itself (268 bp), and were cloned into the multiple cloning site between 
the renilla luciferase gene and a synthetic polyA stretch (Fig. 3.10a). The Dual-Luciferase® 
Reporter System (Promega) was used to measure the activities of both firefly and renilla 
luciferase from the same sample by successive addition of their respective substrates (Beetle 
Luciferin and Coelenterazine). As one plasmid carried both enzyme genes, the activities of 
the renilla enzyme, the transcripts of which contained the sequences of interest, could be 
easily normalized to the firefly activities, excluding different transfection efficiencies. Cells 
were cotransfected with either pSuperior or siRNA for downregulation or with pEGFP 
plasmids for overexpression (for a schematic drawing see Fig. 3.10b). In accordance with the 
results of titration experiments (performed in parallel by L. Schoderböck), a 1:4- ratio of 
reporter and effector plasmids was further used.  
First, assays were performed in HeLa cells, transfected with each of the 3 reporter constructs 
together with either pEGFP-Stau2 (the long isoform of 62 kDa) or pEGFP-ZBP1 using 
FuGENE™ reagent (Roche) for lipofection. As a control, cells were also transfected with 
empty psiCHECK™-2 or pEGFP vectors. After normalization to empty psiCHECK™-2, only a 
slight decrease in activity of the reporter with β-actin 3‘-UTR or zipcode remained when 
Stau2 or ZBP1 was overexpressed, compared to cells transfected with pEGFP alone (see Fig. 
3.11a). When these experiments were repeated with primary neurons, however, the 
outcome was noticeably different. Thus, we decided not to continue using HeLa cells for our 
experiments.  
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Cortical and hippocampal neurons were nucleofected at 0 DIV with one reporter and one 
overexpression (or control) plasmid each and lysed after 24 hours. The measured 
luminescence from the reaction catalyzed by renilla luciferase was normalized to the 
luminescence from firefly luciferase, and then all results were normalized to the activities 
from cells transfected with empty psiCHECK™-2 and cells transfected with pEGFP. As shown 
in Fig. 3.11b, there were no significant differences between cortical (green bars) and 
hippocampal neurons (blue bars). Surprisingly, only the reporter containing the β-actin 
coding sequence and zipcode was regulated differentially by the overexpression of ZBP1 and 
Stau2 to a significant extent (p <0.05). Compared to pEGFP alone, pEGFP-Stau2 expression 
caused a 2-fold increase in luciferase activity, with a slightly bigger increase in hippocampal 
neurons. pEGFP-ZBP1 overexpression led to a similar effect. The expression of the renilla 
luciferase genes with a β-actin 3’-UTR or zipcode was not significantly affected by Stau2 or 
ZBP1, although there might be a trend towards a minor repressive effect.  
Luciferase assays were also performed after knockdown of Stau2 with Accell® siRNA or with 
the pSuperior plasmid siStau2-2. Cortical neurons were transfected at 0 DIV and lysed after 4 
days. In relation to siNT treated neurons, siStau2-treated cells seem to lead to a minor 
repression of the expression of reporters with the β-actin 3’-UTR (Fig. 3.11c, blue bar). 
Treatment with siZBP1 should not show any effect, as it did not lead to sufficient down-
regulation of ZBP1 protein. Interestingly, there was a small effect in the opposite direction 
for Stau2 (red bar). Although these results would principally be in agreement with my 
expectations, both effects are probably negligible. Contrary to the results obtained with 
siRNA, identical experiments using the plasmid siStau2-2 (and Stau2 mismatch as a control) 
led to somewhat elevated activities of luciferase with the β-actin 3’-UTR (Fig. 3.11c, right 
diagram). For one experiment, the reporter containing the coding sequence was also used. 
Stau2 downregulation caused reduced activities of this reporter, which would correspond to 
Stau2 overexpression leading to increased activities. Certainly, these experiments need to be 
repeated to obtain robust and reliable results. However, by plating triplicates of every 
sample relatively large amounts of cells were needed. Considering that not every cell culture 
or transfection was usable, achieving a high enough number of independent experiments 
was not within the reach of this diploma thesis.  
As we could not exclude that small differences between human and rat β-actin sequences 
would possibly influence the results of experiments performed in rat neurons, identical 
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psiCHECK™-2 constructs were cloned with sequences from rattus norvegicus, yet preliminary 
tests did not hint at any species-specific divergence (L. Schoderböck, personal 
communication). 
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3.10 - Luciferase assay  
(A) Plasmid map of PsiCHECK™-2 (Promega) which carries genes for both renilla and firefly luciferase. 3 
stretches of various lengths of the human β-actin sequence (ranging from 273bp to 1357bp) were cloned into 
the MCS at the end of the renilla gene: the zipcode, the whole 3’-UTR, and the zipcode with the coding region 
(designed by L. Schoderböck)  
(B) Schematic drawing of the pEGFP-vector and the pEGFP-Stau2 and pEGFP-ZBP1 overexpression constructs. 
  
      vector size 
psiCHECK-2 human β-actin coding region +zipcode     (7630 bp) 
psiCHECK-2 human β-actin 3‘-UTR         (6849 bp) 
psiCHECK-2 human β-actin zipcode                     (6510 bp)  
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3.11 - Regulatory activity of Staufen2 on luciferase reporters containing different β-actin sequence 
fragments 
(A) Luciferase assays in HeLa cells, 1 day after lipofection with pEGFP, pEGFP-Stau2 (blue bars) or pEGFP-ZBP1 
(red bars). All luciferase activities were normalized to those of cells transfected with empty psiCHECK2-vector, 
and to cells transfected with pEGFP. 
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(B) Luciferase assays in cortical (green bars) and hippocampal neurons (blue bars) after overexpression of Stau2 
or ZBP1 (0+1 DIV; 3 individual experiments with hippocampal and 3 with cortical neurons). Luciferase activities 
were normalized as before. Error bars indicate standard deviation, asterisks indicate significance (* p< 0.05) 
according to student’s t-test.   
(C) Luciferase assays in cortical neurons after 4 DIV of knockdown with siRNA targeting Stau2 and ZBP1. Only 
psiCHECK2 vectors with the β-actin 3‘-UTR were used for transfections, 2 experiments were performed.  
Luciferase activities were normalized to transfections with psiCHECK2 and Non-targeting siRNA (left table). 
After downregulation of Stau2 with the pSuperior plasmid siStau2-2 (2 experiments with the β-actin 3‘-UTR 
construct, 1 with the β-actin coding region+zicode construct), results were normalized to the activities of Stau2 
mismatch (right table).  
 
 
3.6 Lim kinase1, another candidate for the regulation by Staufen2? 
 
To examine how a different mRNA than β-actin would behave during the same experiments, 
another available psiCHECK™-2 construct (cloned by L. Schoderböck) was included in some 
luciferase assays, containing the 3’-UTR of Lim kinase 1 (LimK1). It codes for a 
serine/threonine kinase that is involved in brain development (Goda et al., 2002) 
phosphorylating actin binding proteins thereby inducing cytoskeletal reorganization (Yang et 
al, 1998). It is regulated by different signaling pathways and was also identified as a target of 
the brain-specific microRNA miR-134, which binds in the 3’-untranslated region of LimK1 
(Schratt et al, 2006). Stau2 knockdown using siStau2-2 had an effect on the LimK1 reporter 
similar to its effect on the β-actin reporter – the luciferase activity was again upregulated, 
which could mean that this effect was not necessarily specific (Fig. 3.12a). An experiment 
using siRNA targeting Stau2 showed only very small change of activity when compared to 
non-targeting siRNA treated or samples without any effector (named “untransfected” in Fig. 
3.12a). Regarding β-actin, the effect caused by knockdown with siRNA had also been smaller; 
but in the case of LimK1, the trend of the effect was the same as when using the plasmid. As 
seen in Fig. 3.12b, overexpression of Stau2 had the opposite effect, namely a reduction of 
reporter activity, which was, however, too small to be significant. Overexpression of ZBP1 
led to an equally small increase of activity.  
 
A quantification of LimK1 mRNA levels by qPCR in parallel with β-actin supported the 
luciferase assay results. Although changes were not big, ranging from a 55% increase of 
LimK1 mRNA quantities in siStau2-treated neurons to a 30% decrease in neurons expressing 
Stau2-pEGFP, the reaction of LimK1 mRNA was significantly different between Stau2 up- and 
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downregulation. Since the behavior of LimK1 was not identical with that of β-actin, this 
indicated that the results presented so far were not due to unspecific effects. While this 
preliminary outcome does not allow for safe conclusions regarding a regulatory influence of 
Stau2 on LimK1 expression, I nevertheless regard it as an interesting potential candidate for 
future investigations. 
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3.12 – Influence of Stau2 on LimK1 expression  
(A) Expression of psiCHECK2 luciferase reporters with the LimK1 3’-UTR after Stau2 knockdown with the 
pSuperior plasmid siStau2-2 (2 experiments) or with the Accell® oligo siStau2 (1 experiment) for 4 days (blue 
bars).  Luciferase activities were normalized to psiCHECK2, as well as to either the Stau2 mismatch plasmid or 
to Non-targeting siRNA (green bars). The activity of cells transfected with Non-targeting siRNA compared to 
untransfected cells is shown by the dark green bar. 
(B) Luciferase reporters with LimK1 3’-UTR after Stau2 overexpression for 1 day (2 experiments). Activities are 
normalized to psiCHECK2 and pEGFP. (C) Quantification of LimK1 mRNA levels by qPCR after Stau2 knockdown 
with siRNA (3+3 DIV) or the plasmid siStau2-2 (0+4 DIV) and after Stau2 overexpression (2 individual 
experiments for each condition). 
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IV Discussion 
4.1  Establishing knockdown of Staufen2 and ZBP1 by siRNAs 
The aim of this project was to investigate the actions of RNA-binding proteins, such as Stau2 
or ZBP1, on localized mRNA in neurons. Therefore, the first step was to establish successful 
knockdown of these proteins in primary hippocampal neurons. In particular the 
downregulation of ZBP1 was problematic, which works well in several cell lines (Hüttelmaier 
et al., 2005), but did not yet work in primary neurons. Cell lines, however, may not reflect 
the best model for the physiologic state of a neuron. Although primary dissociated cultures 
are not perfect either - for example naturally neurons are surrounded by a different micro-
environment within their tissue and exposed to growth factors, different oxygen levels, etc. - 
it can be assumed that they mimic real conditions closer than cell lines. 
To achieve downregulation, the method of RNA interference was used, where target mRNAs 
are recognized by siRNA, consisting of symmetrical duplexes of 19-21 bps with 3‘-overhangs.  
This method can induce efficient and durable gene silencing through post-transcriptional 
mRNA cleavage, although it may also cause side effects, such as the overloading of 
microRNA processing machinery or the activation of protein kinase R (Sledz et al., 2003). Off-
target effects can be caused by the incorporation of the sense strand into RISC, which 
sometimes leads to unspecific alterations of gene expression (Jackson et al., 2003). 
Additionally, the transfection procedure itself can be stressful for cultured neurons. Thus, a 
specially modified siRNA provided by Accell® was tested, which can enter the cell without 
any additional transfection procedure (Fig. 3.1).  Viability and transfection efficiencies were 
higher than with conventional siRNA delivery approaches and treatment with siRNA 
targeting GAPDH led to a strong knockdown of GAPDH mRNA levels, as assessed by 
quantitative real-time PCR, in comparison to untreated cells. To exclude unspecific changes 
caused by the siRNA reagent, non-targeting (NT) siRNA was used as a negative control for 
further experiments, which did not cause significant changes in mRNA levels (Fig. 3.2). Thus, 
after modifications of the protocol provided from the company, Accell® siRNAs presented a 
suitable method for the downregulation of expression in hippocampal neurons. As the 
efficiency of knockdown by siRNA is also dependent on the specific sequence of the 
oligonucleotide, four different siRNAs targeting either Stau2 or ZBP1 were tested. Stau2 and 
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ZBP1 mRNA levels after transfection were determined by qPCR and only the siRNAs leading 
to the strongest knockdown were chosen for the following experiments. In particular, the 
effects of the four different oligonucleotides targeting ZBP1 varied considerably (Fig. 3.3).  
As a significant reduction of not only mRNA, but also protein levels would be essential for 
further experiments, the effects of siRNA on Stau2 and ZBP1 protein levels were tested 
performing Western blot experiments with protein extracted from siRNA treated and 
untreated neurons at 3+4 DIV. Stau2 oligonucleotides successfully reduced Stau2 protein 
levels down to 29% when compared to controls, either NT oligonucleotides or siRNA 
targeting GAPDH. Interestingly, the different isoforms of Stau2 were observed to be affected 
to a varying extent, with the 59 kDa isoform being most severely reduced and the smallest 
isoform (52 kDa) only being knocked down to 55% of the control (Fig. 3.4d).  
Unfortunately, the knockdown of ZBP1 protein was less promising, as there was no 
significant reduction seen after treatment with either siRNA or different sh-plasmids. Even 
the reduction of ZBP1 mRNA to roughly 33% of control mRNA levels was variable and not 
always achieved. Thus, the change may have been too small to translate into detectable 
protein level changes, or alternatively, ZBP1 protein was too stable to be affected by RNA 
interference after 3 to 4 days. Importantly, ZBP1 protein levels were also not affected by 
knockdown of Stau2, suggesting there is no direct influence of Stau2 on ZBP1 levels (Fig. 
3.4c). 
 
4.2. The effects of Staufen2 on β -actin 
4.2.1  Staufen2 affects β -actin mRNA levels dependent on conditions 
A potential target of these RBPs is β-actin, an actin isoform responsible for dynamic 
cytoskeletal structures that are needed during axonal growth or spine formation in neurons.   
The β-actin transcript was shown to be regulated both by ZBP1 (Ross et al., 1997) and Stau2 
and localizes together with Stau2 in dendrites of mature neurons (Goetze et al., 2006). To 
investigate the effects of Stau2 on β-actin in developing neurons, β-actin mRNA levels after 
Stau2 knockdown were assessed by qPCR. 
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While treatment with Stau2 siRNA led to a robust decrease of Stau2, β-actin mRNA levels 
were not significantly altered (Fig. 3.5a) in young hippocampal neurons, as would have been 
expected from previous unpublished results in the lab. One potential reason why smaller 
changes in transcript levels may have been difficult to detect could be that β -actin is very 
abundant in the cell in comparison to other RNAs, and the analysis of obtained qPCR results 
relied on the normalization to reference gene levels.  
In preceding studies in the lab, the knockdown of Stau2 had led to a reduction of β-actin 
mRNA levels. Thus, a comparison of the novel siRNAs to the knockdown using short hairpin 
plasmids, which had been shown to have an effect (siStau2-2, Goetze et al., 2006) was 
carried out, to rule out that a difference of transfection method was responsible for the 
divergent results. Amaxa® nucleofection with pSuperior plasmids targeting Stau2 yielded 
comparable knockdown levels of Stau2 mRNA, although they appeared to be slightly weaker 
(Fig. 3.4a). To compare both methods for knockdown more accurately, pSuperior plasmids 
were designed carrying the exact same sequences as the corresponding Accell® siRNAs. The 
short hairpin-plasmid targeting Stau2 (shStau2) led to a reduction of Stau2 mRNA, but to a 
lesser extent. The fact that the knockdown in Accell® siRNA treated cells was roughly 10% 
more potent indicates that the targeting sequence itself is no sufficient explanation for a 
difference between these two methods. Knockdown of ZBP1 mRNA levels with shZBP1 could 
not be achieved to significant levels. As far as protein levels are concerned, both siRNA and 
pSuperior transfection led to very similar results, also shStau2 and siStau2-2 reduced the 
middle isoform of 59 kDa most efficiently. Thus, differential expression of Stau2 isoforms 
does not seem to be a reason for conflicting effects on β-actin levels.  
Another difference between the short hairpin and Accell® knockdown method lies in the age 
of the transfected cells. While neurons were transfected with plasmids before plating and 
usually analyzed after 4 DIV, siRNAs were added after adherence of the cells at 3 DIV. 
Therefore, Stau2 siRNA treatment before plating was attempted, which indeed led to a 
knockdown of β-actin levels to roughly 50% (Fig. 3.5). Unfortunately, these results were 
obtained only from one successful experiment and would need to be confirmed. Even 
though Stau2 is equally downregulated in both cases, β-actin mRNA levels seemingly change 
when neurons are transfected with Stau2 knockdown plasmids before plating, but not when 
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treated with siRNA against Stau2 at later stages. This would suggest that the influence of the 
trans-acting factor on β-actin messages is more severe at an early developmental stage. 
 
4.2.2  Staufen2 downregulation and the actin cytoskeleton 
The effect of Stau2 on β-actin protein levels was assessed by immunohistochemistry or by 
Western blot. Amounts of total β-actin protein on Western blots (stained with monoclonal β-
actin antibodies) seemed unaffected by both overexpression of Stau2 and ZBP1 and 
knockdown of Stau2 with different methods. Yet measuring the intensities of antibody 
labeled protein bands is not a very sensitive method, as it requires consistent antibody 
quality and errors may occur due to normalization to the loading control. Thus very small 
changes might easily have been missed. Importantly, even with reasonably good transfection 
efficiencies a proportion of cells will remain untransfected, so that a putative effect is likely 
to be attenuated.  
Transfected hippocampal neurons on coverslips were also stained with fluorophore-coupled 
phalloidin, which binds F-actin. After knockdown of Stau2, some cells appeared to contain 
lower F-actin levels, although the variation between individual cells on a coverslip or 
between cell cultures was too big to detect clear differences between treated and untreated 
or control cells (Fig. 3.7a). Staining with Stau2 antibodies revealed that Stau2 knockdown 
with siRNA was successful in reducing Stau2 levels in most cells.  As transfected cells could 
not be easily discerned using unlabeled siRNAs, cotransfection with siStau2 and non-
targeting siRNA labeled with a fluorophore (which had initially been used to determine 
transfection efficiencies) was tested once to identify transfected cells. Unfortunately the 
fluorophore may have been bleached during the fixation and staining procedure and the 
signal was very weak in the obtained images.  
In neurons transfected with sh-plasmids by Calcium-Phosphate precipitation, a lack of F-
actin staining could be observed in some transfected cells (Fig. 3.7e, middle panel), while in 
other transfected cells there was no visible change. Transfection before plating (with 
nucleoporation at 0 DIV) unfortunately produced rather unhealthy looking neurons. Cells 
responded rather severely to these treatments at this stage and were not considered for 
further analysis.  
Discussion 
 
87 
 
It should be remembered that phalloidin does not discriminate between the actin isoforms, 
and changes in β-actin mRNA level, for example, have not been observed. Also, the 
phalloidin intensities were measured only in cell bodies, maybe distant processes such as 
growth cones would need to be measured separately to reveal local differences in the actin 
cytoskeleton. Closer investigation and assessment of higher cell numbers would be 
necessary to detect subtle effects of Stau2 on the actin cytoskeleton. 
 
4.3  Translation control of β-actin 
To examine whether Stau2 would control translation of β-actin similarly to ZBP1 
(Hüttelmaier et al., 2005), a more sensitive assay was needed than assessing total protein 
levels by Western blot or phalloidin staining. Therefore, different luciferase reporters were 
created which contained the firefly luciferase gene with either the 3´-UTR of the human β-
actin sequence, just the “zipcode”, or the “zipcode” with part of the coding region (designed 
by L. Schoderböck) (Fig. 3.10). Neurons were cotransfected with these reporter plasmids and 
sh-plasmids or siRNA for downregulation or plasmids overexpressing GFP fusions of Stau2.  
Overexpression of Stau2 led to significant changes of luciferase activity only in one case, 
when the reporter was fused to the zipcode and part of the coding region (Fig. 3.11). This 
suggests that presence of the zipcode, the localization element of the β-actin mRNA 
(Kislaukis et al., 1994), by itself is not sufficient to elicit an effect mediated by Stau2 in 
primary neurons. There is a reported case of an association of an RNA-binding protein with a 
sequence within the coding region, the CRD (coding region instability determinant), namely 
ZBP1 in complex with other proteins acting on the CRD within c-myc mRNA to promote 
stabilization and hinder endonucleolytic cleavage (Weidensdorfer et al., 2009). As the exact 
binding sites of Stau2 on β-actin mRNA have not yet been determined, the existence of a 
comparable region in the coding sequence of β-actin mRNA is probable.  
Overexpression of ZBP1, which is known to repress the translation of mRNA with a zipcode, 
had a similar effect on luciferase activity as Stau2, which may indicate that the observed 
effect is unspecific. Yet ZBP1 is suspected to have a general stimulating effect on translation, 
which makes it difficult to obtain interpretable results and knockdown of ZBP1, which should 
be more informative, was unfortunately not successful.  
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While overexpression of Stau2 caused an increase of luciferase activity from the reporter 
containing the coding region, Stau2 knockdown caused a decrease of its activity in a first 
experiment. The effect of Stau2 knockdown on the β-actin 3´-UTR reporter yielded 
ambiguous results, transfection with the sh-plasmid leading to an increase of translation. 
Since neurons were transfected before plating with nucleofection, the achieved knockdown 
was potentially insufficient. Transfecting with effector and reporter at the same time is not 
ideal for knockdown, as there may be too much protein left at the time of the assay. Thus, a 
better approach might be to knockdown Stau2 some days before transfection with the 
reporter. This would be possible with different transfection methods, for example 
lipofection for cell lines, which is actually very difficult for primary neurons. 
All results were normalized to the luciferase activity of cells transfected with psiCHECK-2 
(without the β-actin sequences) and of cells transfected with pEGFP or mismatch siRNA as 
controls. As transfection with the pEGFP plasmid had a considerable effect on luciferase 
activity on its own, this may have masked some subtle effects after normalization. 
Beside hippocampal neurons, also cortical neurons were used for practical reasons, as they 
can be harvested in much higher cell numbers. That only small differences were observed 
between luciferase activities in these two cell types suggests that Stau2 would have similar 
effects on β-actin in all brain cells. As overexpression of Stau2 in HeLa cells did not cause any 
significant changes, it is conceivable that interaction with other neuronally expressed 
proteins is necessary for the effect of Stau2 on β-actin.  
Whether transcription or translation is regulated cannot be determined by luciferase assays 
alone, as higher efficiency of transcription or greater stability of the transcripts would also 
lead to an increased protein expression. Combining luciferase assays with qPCR would be 
ideal to test whether effects on luciferase activities are transcription- or translation- 
dependent. The relative amount of renilla to firefly luciferase mRNA could have been tested 
with the appropriate primers after isolation of total RNA, yet a problem was encountered: 
although levels of residual genomic DNA within the samples were always very low, there was 
high contamination by plasmid DNA even after prolonged DNase I-treatment, which made 
analysis of these samples by quantitative real-time PCR impossible.  
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4.4 Staufen2 delays mRNA decay 
To investigate a putative role of Stau2 in the stabilization of β-actin mRNA, RNA decay assays 
were performed. After knockdown of Stau2 with siRNA, the RNA synthesis inhibitor 
Actinomycin was added to hippocampal neurons at 6 DIV. The levels of β-actin mRNA at 3 
time points after blocking transcription were quantified by quantitative real-time PCR. As 
relative RNA amounts were determined, selecting suitable reference genes for normalization 
was of high importance. The decay kinetics of different reference genes can vary 
considerably even in untreated cells (Fig. 3.9c), thus using a set of several genes for cross-
normalization is necessary to balance this variation.  
6 hours after adding Actinomycin, the levels of β-actin mRNA had decreased approximately 
by 40%, when comparing neurons treated with siStau2 to neurons treated with non-
targeting siRNA. Thus, in the absence of normal amounts of Stau2 in the cell, the β-actin 
transcript seems to be destabilized and to be degraded faster.  
In agreement with these results, the overexpression of Stau2 led to a slightly enhanced 
stability of the β-actin transcript. It has to be considered, however, that the transfection 
procedure and age of these neurons was different, as neurons were transfected with Stau2-
pEGFP at 0 DIV and analyzed at 1 DIV, and transfection with the empty pEGFP vector by itself 
also had a mild effect.  
 
4.5  Staufen2 and LimK1  
The dynamics of the actin cytoskeleton depends on the presence of β-actin, but is also 
regulated by a broad variety of factors, LimK1 (Lim domain-containing protein kinase 1) 
being one of them. LimK1 stabilizes actin filaments through the inhibition of ADF (actin 
binding depolymerizing factor)/cofilin and thereby controls dendritic spine width. It is 
developmentally regulated and inhibited by a brain-specific microRNA, which binds to a 
target sequence in the LimK1 3´-UTR.  
To investigate whether Stau2 would also influence LimK1 and whether it was affected in a 
similar manner as β-actin, LimK1 mRNA levels were measured by qPCR in parallel to β-actin 
after knockdown or overexpression of Stau2. In contrast to β-actin levels, which were slightly 
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reduced after transfection with pSuperior plasmids, and mostly unaffected by knockdown 
with Accell siRNA, LimK1 mRNA levels increased in neurons transfected with shStau2 
compared to mismatch transfected cells after 4DIV, even more so at 6DIV after knockdown 
with Accell siRNA. Overexpression of Stau2, on the other hand, led to a small reduction of 
LimK1 mRNA (Fig. 3.12c). Correspondingly, knockdown of Stau2 in young neurons led to a 
significant increase of luciferase activity of reporters containing the LimK1 3´-UTR, and Stau2 
overexpression caused a minor decrease of activity.  
Further experiments with LimK1 mRNA were not performed due to time constraints, 
although it might be interesting to see how LimK1 behaves in mRNA decay assays. In situ 
hybridization or immunoprecipitation experiments might give more insight into whether 
LimK1 mRNA is actually present in Stau2 containing granules. The observed negative 
regulation of Stau2 on LimK1 does not necessarily require any direct molecular interaction; 
another possible explanation would be that LimK1 is influenced by proteins which are 
regulated by Stau2. Maybe Stau2 RNPs could enhance the binding of microRNAs to LimK1, as 
overexpression of miR-134 was shown to decrease the activity of LimK1 3´-UTR containing 
luciferase reporters (Schratt et al., 2006). 
 
4.6   Conclusions  
The goal of my diploma thesis was to show the effects of the RBP Stau2 on localized mRNAs 
in developing rat hippocampal neurons. After knockdown of Stau2 in primary neuronal cell 
culture, the degradation of the β-actin transcript was accelerated. The finding that Stau2 
promotes mRNA stabilization, however, does not exclude additional regulatory mechanisms 
for Stau2. Even based on the results obtained from luciferase assays, it is impossible to 
discriminate between enhanced stability and translation. If Stau2 stabilizes β-actin mRNA, 
interaction of Stau2 and β-actin mRNA should increase luciferase reporter activity, while 
translational repression would be expected to counteract this effect. In principle, it is even 
conceivable that both effects occur simultaneously, thus in combination leading to the 
relatively small effects observed in luciferase experiments. 
Possibly changes of total protein levels were not detectable due to incomplete knockdown 
of Stau2 and consequently a decrease of β-actin mRNA levels which was too subtle. Also, β-
actin protein might be too stable for altered mRNA levels to show severe effects on global 
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protein levels. Hence, it can be speculated that Stau2 stabilizes the message RNA during 
transport to a specific dendritic (or axonal) site where it could be translated if needed. This 
in turn would lead to predominantly local changes in β-actin protein concentration.   
Cytoskeletal remodeling at the growth cone or dendritic spine is likely to depend on other 
factors as well. One of the many proteins interacting with the actin cytoskeleton is LimK1, 
which is important in the phase of dendritic spine maturation. With the experiments I have 
described, I was able to show that LimK1 mRNA levels were negatively regulated by Stau2 in 
developing neurons, which makes LimK1 an interesting candidate for further exploration. If 
the observed effects turned out to be specific for young neurons, it could be speculated that 
Stau2 – directly or indirectly – represses LimK1 selectively during early neuronal 
development.  
In summary, the depicted results suggest that localized RNAs, such as β-actin mRNA, are 
regulated by different RNA-binding proteins and that this regulation could be dependent on 
the stage of development. Stau2 and ZBP1 seem to exert diverse actions on their target 
transcript. Yet it remains to be revealed whether their functions are also partly overlapping 
and whether they interact within the same particles, maybe binding different cis-acting 
elements in their target mRNAs. The intricate network of posttranscriptional regulation of 
localized RNAs plays an essential role in neuronal plasticity or development and still holds 
many interesting questions for future investigations. 
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Zusammenfassung 
Viele zelluläre Prozesse erfordern den Transport spezifischer RNAs in bestimmte 
Kompartimente,  wo sie translatiert oder bis zu ihrer Aktivierung gespeichert werden. RNAs 
werden in RNPs (Ribonukleoproteine) verpackt, die in Dendriten in die Nähe von Synpasen 
transportiert werden können. Defekte in der RNA-Lokalisierung werden mit schweren 
neurologischen Störungen in Verbindung gebracht, wie dem Fragiles-X-Syndrom. Ein 
bekanntes Beispiel für lokalisierte RNA in Neuronen ist β-Aktin mRNA, deren Lokalisation in 
axonalen Wachstumskegeln oder Neuriten morphologische Veränderungen des Zytoskeletts 
bewirkt, die während der neuronalen Entwicklung und der synaptischen Plastizität auftreten.  
Zwei Proteine sind bekanntermaßen an diesem Prozess beteiligt: (i) ZBP1 (zipcode-binding 
protein 1), welches an ein 54-nt Lokalisationselement in der β-Aktin 3´-UTR (den 
sogenannten „Zipcode“) bindet und die Proteinsynthese während des Transportes 
supprimiert; und (ii) das doppelsträngige RNA-bindende Protein Staufen2 (Stau2), von dem 
angenommen wird, für die Lokalisation von β-Aktin in Dendriten notwendig zu sein, sowie 
für die Bildung dendritischer Spines in reifen Neuronen. Jedoch ist- im Gegensatz zu ZBP1- 
für Stau2 noch kein bestimmter Aktionsmechanismus beschrieben  worden. Das Ziel meiner 
Diplomarbeit war, die Rolle von Stau2 in der Regulierung von β-Aktin in sich entwickelnden 
Neuronen zu untersuchen. 
Dazu wurde die Expressionsstärke von β-Aktin nach dem Knockdown von Stau2 in 
jungen Neuronen quantitifiziert. Während die Menge an β-Aktin mRNA sich etwas 
reduzierte, blieben die Proteinmengen unverändert. Um Herauszufinden, ob Stau2 ähnlich 
wie ZBP1 die Translation von β-Aktin reguliert, wurden Luciferase-Experimente 
durchgeführt. Während ein Knockdown von Stau2 keinen Effekt hatte, führte die 
Überexpression von Stau2, wie auch ZBP1, zu erhöhter Luciferaseaktivität, wenn das 
Luciferase-Plasmid den β-Aktin Zipcode und einen Teil der kodierenden Region von β-Aktin 
enthielt. Da dieser Assay keine eindeutige Unterscheidung zwischen erhöhter Translation 
und Stabilität zulässt, wurden RNA-Zerfallstests durchgeführt. Die Menge der verbleibenden 
β-Aktin mRNA zu unterschiedlichen Zeitpunkten nach Inhibierung der RNA-Synthese wurde 
mit quantitativer real-time PCR bestimmt. Der Zerfall der β-Aktin mRNA war in Neuronen mit 
reduzierten Stau2 Levels beschleunigt. Demgegenüber hatte die Überexpression von Stau2 
nur einen geringfügig stabilisierenden Effekt.   
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Zusammengenommen zeigen meine Ergebnisse, dass das RNA-bindende Protein Stau2 die 
Stabilität von β-Aktin mRNA in sich entwickelnden Neuronen erhöht, ohne seine Translation 
zu beeinflussen. Da die Gesamtmenge an β-Aktin Protein gleich blieb, ist es denkbar, dass 
Stau2 die Stabilisierung nur vorübergehend während des Transportes fördert, in 
vergleichbarer Weise wie ZBP1 eine vorzeitige Translation für die Dauer des β-Aktin 
Transportes hemmt. Ob β-Aktin mRNA direkt an Stau2 bindet, möglicherweise über eine 
Sequenz innerhalb der kodierenden Region, und ob es in gemeinsamen RNPs mit ZBP1 
interagiert, könnte ein interessantes Thema für zukünftige Untersuchungen sein. Um die 
Rolle von Stau2-RNPs letztendlich aufzuklären, ist es notwendig, die Identität der RNA-
Targets und der Proteininteraktionen von Stau2 zu klären und die Funktionsweise von Stau2 
während des Transportes bzw. in Spines oder Wachstumkegeln im Detail zu beschreiben. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
